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ABSTRACT 
 
 Inflammation is a complex biological response to stress triggered by 
microbial infections. Although inflammation drives microbial clearance, if 
uncontrolled it leads to cellular damage and cell death. Previous studies have 
demonstrated that endoplasmic reticulum (ER) and mitochondrial stress programs 
can contribute to immunity by mediating production of inflammatory cytokines; 
however, the regulatory mechanisms are unclear. By utilizing Brucella abortus 
cattle vaccine strain RB51, we elucidated how ER and mitochondrial stress 
mediate inflammatory responses and the eventual fate of infected cells. Our initial 
findings revealed that RB51-induced programmed cell death (PCD), mediated by 
caspase-2-induced mitochondrial damage, led to activation of proapoptotic 
caspase-3 and -8. Notably, this caspase-2 mediated PCD was accompanied by 
the production of proinflammatory cytokines, TNFα and IL-1β, a phenomenon 
associated with pyroptosis, not PCD. These observations led us to further 
investigate how caspase-2 could regulate inflammation and proinflammatory cell 
death. As early as 2 hours post infection, RB51 triggered activation of ER stress 
sensor, IRE1, leading to increased ROS levels in the mitochondrial network. This 
sharp increase in mitochondrial ROS elicited the recruitment of inflammasome 
component NLRP3 and caspase-2 to the mitochondrial network, which triggered 
mitochondrial damage. Damage promoted release of mitochondrial danger signals 
 
xv 
 
into the cytosol and the activation of the NLRP3-ASC-caspase-1 inflammasome, 
which processes the inflammatory cytokine, IL-1β. Damaged mitochondria are 
usually tagged for removal by a mitochondria-specific form of autophagy called 
mitophagy. We observed that killed RB51 activated a second ER stress sensor, 
PERK, which suppressed IL-1β production. Upon PERK activation, the 
downstream transcription factor ATF4 initiated transcription of Parkin, a key 
regulator of mitophagy, which decreased mitochondrial damage signals and 
activation of the inflammasome. We have discovered that the partnership between 
the ER and mitochondria is essential for mediating inflammatory responses and 
determining cell fate. By fine-tuning the immune response via selective activation 
of ER stress sensors, we have laid the groundwork for therapeutic targeting of 
these regulators in inflammatory diseases associated with cellular stress. 
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Chapter 1 
 
Endoplasmic reticulum and mitochondria: key regulators of cell fate and 
immunity 
 
Introduction 
Exposure to microbial pathogens triggers contextual signals that result in 
host immune responses, defining the outcome of infection. Activation of cellular 
stress programs by infection can trigger the secretion of microbicidal effectors and 
inflammatory mediators. These cellular stress responses protect the cell against 
unfavorable conditions by minimizing damage and maintaining host tissue 
integrity. If cellular stress remains unresolved, these stress programs can initiate 
cell death, thus limiting microbial spread and replication. Two essential organelles, 
the endoplasmic reticulum (ER) and the mitochondrial network, are key platforms 
for sensing and signaling cellular stress. Unresolved or prolonged ER and 
mitochondrial stress are implicated in many inflammatory or degenerative 
diseases. Although key proteins in these stress pathways have been well 
characterized, their crosstalk with innate immune signaling and their role in the 
regulation of host defense are less clear. Recent studies, highlighted in this 
introductory chapter, emphasize the emerging importance of ER and mitochondrial 
stress in infection-induced inflammation.  
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Endoplasmic Reticulum: central hub for signaling integration  
The endoplasmic reticulum (ER) is a dynamic organelle involved in lipid 
production, protein translational modification and protein folding. Stress stimuli 
such as nutrient deprivation or infection can perturb normal ER function and lead 
to an accumulation of misfolded proteins within the ER, triggering the Unfolded 
Protein Response (UPR) [1]. UPR activation begins with dissociation of the ER 
stress chaperone BiP (GRP78) from three UPR stress sensors: ATF6, IRE1, and 
PERK (Fig. 1.1). The unfolded proteins sequester BiP, allowing for the three stress 
sensors to activate signaling pathways aimed at relieving ER stress [2]. These 
three UPR sensors separately regulate the expression of chaperones, cytokines, 
cell death components, as well as translational attenuation. Malfunctions in the ER 
stress response caused by aging, mutations, or environmental factors (e.g., 
infection) can result in various pathologies such as inflammatory and 
neurodegenerative disorders. 
UPR, the stress signaling headquarters 
ATF6: an ER-responsive transcription factor 
 Activating transcription factor 6 (ATF6) is localized to the ER during 
unstressed conditions. Under stress conditions, BiP dissociation allows transport 
of ATF6 to the Golgi apparatus where it is processed by site 1 and 2 proteases 
(S1P and S2P) [3, 4]. Upon cleavage, ATF6 translocates to the nucleus resulting 
in the increased expression of endoplasmic reticulum associated protein 
degradation (ERAD) encoding genes as well as XBP1, a downstream target of 
Figure 1.1: Schematic of ER stress sensors ATF6, IRE1, and PERK.
Accumulation of misfolded or unfolded protein aggregates in the ER lumen, leads
to activation of three ER transmembrane proteins, PERK, IRE1, and ATF6. BiP,
an ER chaperone, normally is bound to the stress sensors and keeps them
inactive. Accumulation of misfolded proteins triggers BiP dissociation from them
to assist with protein folding thus triggering activation of the 3 stress pathways.
Upon activation, PERK phosphorylates eIF2α which inhibits global protein
synthesis and reduces the protein load in the ER lumen. ATF4 expression
increases upon eIF2α phosphorylation and translocates to the nucleus allowing
for transcription of UPR target genes. These genes include CHOP, a
proapoptotic transcription factor that results in cell death if ER stress conditions
persist, and GADD34, which acts as a negative regulator of the PERK pathway
by dephosphorylating eIF2α. Active IRE1 splices XBP1, a mRNA encoding a
transcription factor that can lead to upregulation of ER chaperones and other
UPR target genes. ATF6 activation leads to its translocation to the Golgi where it
is sequentially cleaved by site 1 and site 2 proteases. This leads to the release of
the N-terminal ATF6 fragment which translocates to the nucleus and activates
UPR target genes. In addition to UPR target genes, these three sensor can also
increase expression of proinflammatory cytokines (e.g. IL-6 and TNF) as well as
autophagy proteins – both of which contribute to infection resolution.
3
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IRE1 [5]. The leucine-zipper domain of ATF6 allows for interaction with the ER 
stress response element (ERSE) located in the promoter of UPR-responsive 
genes.  
IRE1: Regulator of mRNA and protein degradation 
 Upon BiP dissociation, Inositol-requiring Enzyme 1 (IRE1), located in the 
ER membrane, dimerizes and autotransphosphorylates, activating its kinase and 
endoribonuclease domains. The endoribonuclease domain splices an unusual 
cytoplasmic mRNA encoding X-box binding protein 1 (XBP1). This allows for 
translation of an active XBP1 transcription factor that upregulates UPR-related 
genes, e.g., that mediate the ER associated degradation pathway (ERAD) [6, 7]. 
Additionally, XBP1 also promotes ER membrane expansion by increasing 
expression of genes involved in phospholipid biosynthesis, thus relieving stress. 
Parallel to ERAD, IRE1 also triggers regulated IRE1-dependent decay, (RIDD) [8], 
a process that specifically degrades mRNAs encoding ER-localized proteins, 
which prevents protein delivery to the stressed ER. Basal RIDD is necessary for 
ER homeostatic maintenance; however, increased RIDD activity during stress 
conditions can induce pro-apoptotic pathways.  
PERK: Suppressor of global translation 
 Protein kinase RNA-like ER kinase (PERK) autophosphorylates its 
cytoplasmic kinase domain when BiP dissociates. After activation, PERK 
phosphorylates eukaryotic translation-initiation factor 2 alpha (eIF2α), preventing 
the exchange of GDP for GTP that is necessary for eIF2α activation [9]. Preventing 
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eIF2α activation reduces global translation, allowing a subset of genes involved in 
ER stress response, autophagy, apoptosis, amino acid metabolism, and 
antioxidant responses to be preferentially regulated. A downstream target of 
eIF2α, activating transcription factor 4 (ATF4), mediates transcriptional induction 
of these genes [10]. Sustained PERK signaling upregulates the pro-apoptotic 
transcription factor C/EBP-homologous protein (CHOP). CHOP facilitates the 
decrease in expression of B-cell lymphoma 2 (Bcl-2), a protein that interacts with 
proapoptotic proteins (e.g., Bax and Bak), thus preventing cell death [11].  
The transcriptional program controlled by these three stress sensors results 
in upregulation of stress chaperone proteins to aid in folding proteins, as well as to 
trigger protein and mRNA degradation to prevent further accumulation of misfolded 
proteins. The initial program triggered by these three sensors is pro-survival; 
however, if the stress is not resolved, these sensors can initiate a pro-apoptotic 
program leading to cell death. Recent advances have shown that, in addition to 
regulating cell survival, ER stress can promote innate immune responses to 
combat microbial infections. 
The ER integrates stress programs with host defense 
 Recent evidence has revealed that ER stress is involved in inflammatory 
responses that aid in infection resolution, as well as tissue damage [12, 13]. All 
three ER stress sensors (IRE1, ATF6, and PERK) can participate in upregulating 
inflammatory processes. The UPR sensors enhance activation of NF-κB, a 
transcription factor that regulates expression of proinflammatory cytokines, via 
different mechanisms. Toll-like receptor activation of XBP1 increases transcription 
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of proinflammatory cytokines IL-6, TNFα, and IFNβ in response to LPS treatment 
[13]. Notably, transcription of the proinflammatory cytokine IL-1β is not dependent 
upon the IRE1-XBP1 axis. In contrast to IRE1, PERK increases cytokine levels by 
suppressing translation of IκB thus allowing NF-κB to translocate to the nucleus 
and induce transcription of proinflammatory cytokines [14]. Additionally, PERK-
induced CHOP increases transcription of another proinflammatory cytokine, IL-23. 
Similar to IRE1 and PERK, ATF6 can also enhance NF-κB activation, although the 
mechanism is not currently known [15].  
Although ER stress-induced inflammation can be protective and aids in the 
clearance of microbial pathogens, it can also be detrimental to the host and 
exacerbate some inflammatory diseases. For instance, ER stress can contribute 
to the progression of Type 2 diabetes by suppressing insulin receptor signaling 
[16]. ER stress can also induce cell death in intestinal epithelial cells, Paneth cells, 
and goblet cells, thus increasing inflammation in inflammatory bowel diseases 
(IBDs), such as Crohn’s disease and ulcerative colitis [17, 18]. Furthermore, ER 
stress-induced inflammation has been implicated in the progression of cystic 
fibrosis and cigarette smoke-induced chronic obstructive pulmonary disease [19], 
both of which are chronic inflammatory airway diseases. There is evidence 
supporting the notion that ER stress-induced inflammation can promote the 
pathogenesis of some chronic diseases such as Type 1 and 2 diabetes, heart 
disease, Alzheimer’s disease, and Parkinson’s disease [20]. Although ER stress 
can aid in the progression of inflammation, ER stress has also been linked to 
autophagy, a cellular process that dampens inflammatory responses [21].  Thus, 
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further study of ER stress to tease out the complex mechanisms that link this 
program to inflammation is warranted. 
Restoration of homeostasis via autophagy or apoptosis 
 The ER stress response is a major pivot point that determines whether a 
cell will survive or die in response to stress. During ER stress, the UPR program 
promotes restoration of ER homeostasis. If homeostasis cannot be restored, 
chronic UPR stress signaling eventually results in programmed cell death, in the 
form of apoptosis. To delay apoptosis, the UPR can trigger autophagy, a pro-
survival dynamic process where cellular components are sequestered by double-
membrane autophagosomes for lysosomal degradation (Fig. 1.2). These cellular 
components can include proteins, damaged organelles, and microbial pathogens. 
Efficient sequestration and clearance of damaged cellular or non-self components 
are crucial for cell survival as well as function. 
Initiation of autophagy begins with the formation of the phagophore, a 
process mediated by the UNC51-like kinase (ULK1) and Beclin-1 initiation 
complex. The interaction between Beclin-1 and Bcl-2, an anti-apoptotic factor, 
prevents assembly of the phagophore, thus inhibiting autophagy [22]. Once 
initiation occurs, the Atg5-Atg12-Atg16L complex and LC3-II promote elongation 
and engulf the designated cargo. This new structure is called the autophagosome, 
which subsequently fuses with the lysosome, leading to degradation of the interior 
cargo.  
Figure 1.2: Illustration of the steps of autophagy. Activation of ULK1
and Beclin-1 complexes in response to certain signals initiates isolation
membrane and the formation of phagophore. The Atg protein complex and
LC3 promote the elongation and capture of cytosolic cargos (e.g. protein
and organelles), leading to the formation of autophagosome.
Subsequently, lysosome fuses with the autophagosome leading to
degradation of the cytosolic cargo. Pro-apoptotic BCL-2 inhibits autophagy
by interacting with Beclin-1. UPR sensors can trigger autophagy by
promoting activation of the initiation and elongation complexes. IRE1
triggers autophagy by activating JNK thus leading to phosphorylation and
dissociation of Bcl-2 from Beclin-1. Moreover, PERK and IRE1 mediate
Beclin-1 and ULK1 transcription whereas ATF6 triggers phosphorylation of
Beclin-1 thus triggering Beclin-1 dissociation from Bcl-2. PERK promotes
elongation of the phagophore by inducing upregulation of Atg proteins and
triggering LC3 conversion. This schematic was adapted from Kang et al.
Cell Death Differ, 2011. 18(4):571-80.
8
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The three UPR sensors regulate many of the autophagic proteins through 
different mechanisms. Activation of the PERK-eIF2α axis induces Atg12 
upregulation, conversion of LC3-I to LC3-II, and subsequently facilitates 
autophagosome formation [23]. Moreover, PERK-induced ATF4 and CHOP 
regulate LC3, Atg5, and ULK1 transcription, further demonstrating a role for PERK 
in autophagy initiation and elongation [24]. IRE1 recruits tumor-necrosis factor 
receptor associated factor 2 (TRAF2), thus triggering JNK activation. JNK 
phosphorylates Bcl-2, which promotes its dissociation from Beclin-1 and leads to 
subsequent autophagy induction [25, 26]. Besides regulating activation, IRE1 can 
also modulate Beclin-1 expression through XBP1. Lastly, recent evidence has 
uncovered a role for ATF6 in autophagy induction through death-associated 
protein kinase 1 (DAPK1). DAPK1 promotes autophagy by phosphorylating Beclin-
1, dissociating it from autophagy negative regulator Bcl-2 [27]. These data 
demonstrate an intricate redundancy in ER stress-induced autophagy. Autophagy 
occurs throughout the life of a cell, working to maintain or restore metabolic 
homeostasis, and may be a critical determinant in ER stress-induced cell survival 
or death.  
 If restoration of homeostasis is not achieved, IRE1-induced JNK activation 
triggers activation of the proapoptotic protein BIM while deactivating the 
antiapoptotic protein Bcl-2 [26], thus committing the cell to apoptosis. 
Phosphorylation of Bcl-2 triggers dissociation from BAX and BAK, two proapoptotic 
proteins. Upon release and activation, BAX and BAK form an oligomeric pore in 
the outer mitochondrial membrane, facilitating the release of cytochrome c into the 
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cytosol and activation of proapoptotic caspases [28]. Similar to IRE1, CHOP-
induced apoptosis involves interaction with members of the Bcl-2 family of 
proteins. One such interaction involves transcriptional downregulation of Bcl-2, 
thus preventing the expression of apoptosis repressors. CHOP can also induce 
the transcription of BIM, which plays a role in mitochondrial-mediated apoptosis. 
BIM serves as a death ligand and specifically interacts with certain antiapoptotic 
Bcl-2 protein members, which leads to apoptosis induction [26].   
A second mechanism of ER stress-induced apoptosis involves calcium 
signaling.  ER stress is accompanied by alterations in calcium levels due to calcium 
leakage or efflux from the ER [29]. CHOP-dependent activation of the ER oxidase 
1α triggers ER calcium release by activating the ER calcium channel IP3R [30]. 
Cytoplasmic calcium activates the calcium-sensing enzyme CaMKII, which in turn 
triggers downstream signaling. Moreover, excess cytosolic calcium is absorbed 
into the matrix of mitochondria, leading to changes in membrane potential, as well 
as promoting the transfer of cardiolipin from the inner to outer mitochondrial 
membrane (a signal for targeted insertion of proapoptotic Bcl-2–family proteins Bid 
and Bax into membranes) [31]. Besides affecting mitochondria, ER-induced 
calcium release alters phospholipid scramblases that transfer phosphatidylserine, 
a lipid that serves as a signal for clearance of apoptotic cells by phagocytosis, to 
the outer leaflet of the plasma membrane. 
 Together, these studies illustrate that the ER can recruit mitochondria to aid 
in its apoptotic program. This is not surprising because (a) the ER and 
mitochondria share close contacts throughout the cytosol [32], and (b) many 
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apoptotic proteins between the ER and mitochondria overlap [33]. Due to the close 
proximity of these two organelles, crosstalk is quite frequent and can influence the 
stress level within each organelle. Communication between the ER and 
mitochondria takes place at specialized contact sites called mitochondrial 
associated membranes (MAMs) [33]. At the MAMs, calcium is released from the 
ER through the IP3R channel and is taken up by the calcium channel VDAC located 
on the outer mitochondrial membrane [34, 35]. Calcium transfer [36] between 
these two organelles is important for cell metabolism and intracellular calcium 
signaling. Any alterations in calcium transfer (mitochondrial calcium overload, 
deficiency in ER calcium leakage, etc.) can have profound effects on the cell and 
can trigger cell death or autophagy [37]. Thus, the integration of mitochondrial 
signaling pathways appears to contribute to ER-mediated cell fate decisions. 
Mitochondria: converting signaling into action 
 Cells activate multiple mechanisms to re-establish homeostasis and to 
repair stress-induced molecular damage. Mitochondria are involved in the 
response of cells to a wide number of perturbations including, but not limited to, 
oxidative stress and pathogen invasion. Furthermore, mitochondria can be both 
the substrate of autophagic degradation (mitophagy [38]) or spared by the 
autophagic machinery to ensure energy production during stress. Similar to the 
ER, mitochondria are particularly sensitive to endogenous stress and are another 
major sensor of environmental stress. During mitochondrial stress, the 
mitochondrial membrane depolarizes, reactive oxygen species (ROS) production 
increases, and mitochondrial contents can be released into the cytosol to act as 
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danger signals. Several human diseases, including neurodegenerative diseases 
and cancer, are associated with mitochondrial dysfunction and increased ROS 
damage [39-42]. To promote survival under such conditions, mitophagy prevents 
the accumulation of nonfunctional and damaged mitochondria that contribute to 
human pathologies.  
Cell fate hinges on mitochondrial membrane integrity 
Mitochondria are the main site of ATP production and are sensitive to 
conditions that might disturb membrane potential. In healthy mitochondria, a high 
proton gradient, or membrane potential (Δѱm), exists across the mitochondrial 
inner membrane due to protons pumped into the intermembrane space by the 
respiratory chain protein complexes located in the inner membrane [43]. The 
proton pumping occurs as a result of the electron transport chain (ETC), which 
provides free energy for transferring protons against their electrochemical 
gradient. In addition to proton pumping, the ETC also mediates ATP production 
and oxygen consumption in mitochondria, a process called oxidative 
phosphorylation [44]. Defective oxidative phosphorylation reduces metabolic 
capacity, which is a sign of mitochondrial stress. Perturbations in oxidative 
phosphorylation can lead to reduced ATP production, depolarization of the inner 
membrane, and excessive reactive oxygen species (ROS) production [44].  
Inner mitochondrial membrane depolarization induces opening of the 
mitochondrial permeability transition pore (MPTP) [45]. This pore is a protein 
complex consisting of VDAC, cyclophilin D (CypD), and adenine nucleotide 
translocase that, when opened, allows small hydrophilic molecules (e.g., calcium 
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ions and ATP) to cross the mitochondrial membrane in response to membrane 
depolarization. The influx of calcium ions causes mitochondrial swelling, and 
eventually the outer membrane ruptures, allowing mitochondrial contents to leak 
into the cytosol [46, 47]. Alternatively, release of mitochondrial contents can be 
induced upon pore formation in the outer membrane. 
Proapoptotic Bid mediates oligomerization of two pore forming proteins, 
BAK and BAX, in the outer mitochondrial membrane [28]. Activation of Bid can be 
triggered by several host proteases, including caspase-8, cathepsin, and calpain, 
with caspases predominantly cleaving Bid during apoptosis. Release of 
mitochondrial intermembrane space (IMS) proteins into the cytosol generally 
triggers cell death (Fig. 1.3) [47]. IMS proteins (e.g., cytochrome c, SMAC, OMI, 
APAF-1) can activate proapoptotic proteins in the cytosol leading to apoptosis. 
Notably, cytochrome c release drives the assembly of the apoptosome [48, 49], a 
multiprotein complex that cleaves and activates procaspase-9. Upon activation, 
caspase-9 cleaves procaspase-3, resulting in the execution of apoptotic cell death 
[48, 49]. These observations indicate that proper regulation of mitochondrial 
membrane potential is critical for viability of the cell as well as the organism as a 
whole. 
Mitochondria, one platform for inflammasome assembly  
 Besides triggering cell death, outer membrane rupture can also trigger 
inflammation due to the release of mtROS and mtDNA. These two mtDAMPs can 
activate inflammasomes, large immune signaling machines that are responsive to 
microbial pathogens and endogenous stressors [50, 51] and that activate the 
Figure 1.3: Mechanisms of mitochondrial outer membrane
permeabilization. During homeostasis, mitochondria maintain high
membrane potential (Δѱm), have an intact outer membrane, and IMS
proteins (e.g. cytochrome c) are retained. In the presence of an apoptotic
signal, Δѱm drops significantly, leading to the release of IMS proteins by:
(A) sustained opening of the mitochondrial permeability transition pore
(MPTP), (B) Bid-mediated oligomerization of Bak and Bax on the outer
mitochondrial membrane or (C) rupture of the outer mitochondrial
membrane. Once cytochrome c is released into the cytosol, it interacts with
Apaf-1 and caspase-9 to form the apoptosome, a multiprotein complex that
activates caspase-3 and induces apoptosis (programmed cell death). This
schematic was adapted from Bronner et al. EMBO J, 2014. 33(19):2137-9.
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potent proinflammatory cytokines, interleukin-1β (IL-1β) and IL-18 [51]. Canonical 
inflammasomes are multiprotein complexes that consist of an inflammasome 
sensor, the adaptor protein ASC, and caspase-1. Once formed, the inflammasome 
triggers caspase-1 induced proteolytic processing of proIL-1β and proIL-18. 
Microbial infections and some environmental stress conditions can trigger 
activation of the inflammasome [52, 53]. The NLRP3 inflammasome sensor is 
unusual because its activation is associated with diverse stress conditions, such 
as excessive mtROS, lysosomal damage, ER stress, or mitochondrial damage [54, 
55], although whether these stresses employ a common ligand to activate NLRP3 
is a question that is actively debated.  
ROS produced by mitochondria can activate the NLRP3 inflammasome, a 
process that occurs at MAMs [55], possibly concomitant with the cytosolic release 
of mtDNA [46, 47]. Mitochondria are thought to be important for NLRP3 
inflammasome activation in response to various noninfectious agents, including 
uric acid and silica [56]. MtROS production induced by specifically inhibiting 
Complexes I and III (protein complexes of the ETC) leads to NLRP3 inflammasome 
activation [57]. Increased ROS levels increase the association of NLRP3 with 
thioredoxin-interacting protein (TXNIP) [58]. Typically, TXNIP is constitutively 
bound to the oxidoreductase thioredoxin 1 (TRX1). Upon an increase in mtROS 
concentration, this complex dissociates and TXNIP binds to and activates NLRP3 
once it translocates to the mitochondria [59, 60]. These observations suggest that 
mitochondrial-associated TXNIP might aid in the release of mitochondrial contents, 
thus increasing the chances for inflammasome activation. Permeabilization of the 
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outer mitochondrial membrane not only leads to the release of cytochrome c, but 
also mtDNA into the cytosol. During mitochondrial stress, ROS levels rapidly 
increase, leading to oxidation of proteins and mtDNA. Studies have shown that 
oxidized mtDNA directly binds to NLRP3 leading to inflammasome formation and 
activation [61, 62]. Additionally, macrophages lacking mtDNA were severely 
deficient in IL-1β production when treated with LPS and ATP, potent 
inflammasome stimuli [62]. Studies have suggested that mtDNA may also trigger 
activation of the AIM2 inflammasome. AIM2 is a large cytosolic protein that senses 
and binds to dsDNA [63, 64]. Upon binding, a conformational change is induced 
promoting oligomerization of the AIM2 inflammasome. Transfection of mtDNA into 
macrophages leads to AIM2 activation and IL-1β production [62], and the 
introduction of DNase I into the cytosol prevented IL-1β production in 
macrophages. These data show that mitochondrial contents can serve as 
important mediators of inflammation. In addition to providing inflammasome-
activating ligands, mitochondria can also act as a platform where inflammasome 
complexes can oligomerize. In untreated macrophages, NLRP3 resides in the 
cytosol in an inactive state. Danger signals induce NLRP3 oligomerization and 
recruitment to mitochondria by interaction with the mitochondria-associated 
adaptor protein MAVS [65]. Mitochondria-associated NLRP3 then promotes 
recruitment of the cytosolic adaptor protein ASC and caspase-1, leading to 
cleavage of pro-IL-1β to its active, secreted form [66]. 
Although many pathophysiological conditions and chemically unrelated 
stimuli (e.g., ROS, toxins, uric acid, etc.) activate the NLRP3 inflammasome, few 
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studies have highlighted a direct interaction between NLRP3 and these molecular 
entities. Therefore, it is unclear how these different stimuli all lead to same 
outcome, NLRP3 activation. A recent study uncovered that many NLRP3 
activators (e.g., bacterial pore-forming toxins, nigericin, ATP, and particulate 
matter) cause mitochondrial perturbation and increased ROS production, but 
neither were required for NLRP3 activation [67]. Instead, it was suggested that the 
common activity induced by all NLRP3 agonists is K⁺ efflux. Notably, reduction of 
intracellular K⁺ concentration was sufficient to activate NLRP3. These results were 
the first to demonstrate that K+ efflux may be a common mechanism that drives 
NLRP3 activation during diverse stress conditions. These findings contrast with 
previous work that demonstrates a role for mitochondria in inflammasome 
activation in response to LPS + ATP treatment. These observations would suggest 
that at least two pathways for NLRP3 inflammasome activation (mitochondria-
dependent and mitochondria-independent) might exist, perhaps acting in a cell 
and/or stimulus-specific manner.   
Mitophagy maintains the integrity of the mitochondrial network 
When dysfunction occurs within mitochondria, dysfunctional or damaged 
mitochondria can be removed without comprising the entire mitochondrial network. 
Low ATP production, enhanced ROS generation, or calcium imbalance serve as 
signs of dysfunctional or damaged mitochondria, thus leading to induction of a 
mitochondrial specific form of autophagy called mitophagy (Fig. 1.4). Healthy 
mitochondria can divide into functional progeny that can reintegrate into the 
mitochondrial network by fusion. In contrast, dysfunctional mitochondria are 
Figure 1.4: Mitophagy, the labelling and removal of damaged
mitochondria. When mitochondria are damaged and lose membrane
potential, the kinase PTEN-induced putative kinase protein 1 (PINK1)
accumulates and recruits the E3 ubiquitin ligase Parkin to the damaged
mitochondrion. Parkin ubiquitylates mitochondrial proteins (e.g. VDAC,
MFN1 and 2) and causes mitochondria to fragment and be captured by the
phagophore that then fuse with lysosomes. This schematic was adapted
from Popovic et al. Nat Med, 2014. 20(11):1242-53.
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specifically separated from the network and destined for mitophagic degradation 
[40]. Intact mitochondria are constantly importing the kinase PINK1 into the matrix 
where it is cleaved by the protease PARL [38]. PINK1 accumulation on the outer 
mitochondrial membrane serves as a flag for mitochondrial dysfunction [68]. If the 
Δѱm decreases, PINK1 accumulates on the outer membrane leading to the 
recruitment of the ubiquitin ligase Parkin, which ubiquitinates mitochondrial outer 
membrane proteins such as MFN1 and MFN2 (mitofusin 1 and 2, regulators of 
mitochondrial fusion). By favoring proteasomal degradation of MFN1 and MFN2, 
Parkin suppresses mitochondrial fusion and promotes fragmentation of the 
network [69]. Mitochondrial fragmentation allows for the capture of 
damaged/dysfunctional mitochondria by autophagosomes. A recent study 
revealed that the ER stress sensor PERK can regulate Parkin-mediated 
mitophagy. Parkin expression increased during ER stress in a manner dependent 
on the PERK/ATF4 branch of the UPR [70]. Upon induction, ATF4 bound to a 
CREB/ATF site within the Parkin promoter triggering parkin transcription. Although 
Parkin protects cells from ER stress-induced cell death via the removal of 
damaged mitochondria, it does not reduce the level of ER stress within the cell. 
These observations support the notion that crosstalk between the ER and 
mitochondria is critical to maintaining cell survival under stress.  
Maintaining integrity of mitochondria is crucial for cell viability because 
mitochondria are critical regulators of cell death and are responsible for a variety 
of metabolic functions. Mitochondrial dysfunction is a key feature of 
neurodegeneration. Mutations in mitochondrial DNA and oxidative stress both 
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contribute to aging, which is the greatest risk factor for neurodegenerative 
diseases such as Alzheimer’s and Parkinson’s disease. In Alzheimer’s disease, 
mitochondrial ROS generation and inhibition of energy metabolism increase 
amyloid-β peptide levels, the primary component of senile plaques [39, 42, 71]. 
For Parkinson’s disease, defects in mitochondrial associated pathways and 
proteins contribute to the progression of the disease. Decreased activity or 
mutations in genes for Complex I (a major contributor member of the ETC) can 
cause Parkinson’s disease [41]. Additionally, mutations in the mitophagy regulator 
Parkin increases cell death and progression of Parkinson’s disease [72, 73]. These 
observations indicate that maintaining integrity of the mitochondrial network is not 
only important on a cellular basis but on an organismal basis as well. 
Conclusions 
Recent findings highlight the contribution of the mitochondria and ER to 
regulation of inflammation and disease progression. The pathways and players of 
the mitochondria and ER overlap and are complementary. Furthermore, 
mitochondria are tethered to the ER, providing the conditions for constant 
communication between the two organelles [74-76]. ER-mitochondrial crosstalk is 
important for initiating cell death during certain stress contexts; therefore, it is 
reasonable to propose that this crosstalk may contribute to initiation of 
inflammatory responses. Elucidating the context and mechanisms by which ER-
mitochondrial crosstalk controls inflammation may aid in identifying targets that 
modulate many inflammatory and neurodegenerative diseases.  
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 To investigate if ER-mitochondrial crosstalk is essential in mediating 
inflammation, I utilized the Gram-negative bacterium, Brucella abortus RB51, an 
attenuated cattle vaccine strain. Typically, virulent Brucella strains (e.g. S2308, 
16M) acquire ER membrane when generating the Brucella containing vacuole, an 
intracellular environment that is conducive for microbial replication [77–79]. 
Attenuated strains like RB51, are unable to create the BCV; however, these strains 
can still traffic to the ER [80, 81] (Fig. 1.5). Attenuation is due to multiple mutations 
in the RB51 genome, including a mutation that prevents addition of the O antigen 
during Brucella lipopolysaccharide (LPS) biosynthesis [82]. Attenuated Brucella 
species have been shown to trigger ER and mitochondrial stress during infection 
as well as eliciting proinflammatory responses [83–87]. Therefore, RB51 served 
as a tool for elucidating the role of ER and mitochondrial stress in inflammation 
regulation.  The following chapters will demonstrate that ER stress can modulate 
inflammation and cell death via two stress sensors. Chapter 2 highlights the 
consequences of uninhibited inflammation - cell death. Damaged mitochondria 
release apoptotic molecules thus triggering an unique type of cell death that is 
reminiscent of both apoptosis (silent) and pyroptosis (inflammatory). In chapter 3, 
I discuss how IRE1 drives mitochondrial damage, leading to the release of 
mitochondrial danger signals required for NLRP3 inflammasome activation. 
Chapter 4 reveals that PERK suppresses NLRP3 inflammasome activation 
through Parkin-dependent mitophagy, and that induction of mitophagy leads to the 
removal of dysfunctional mitochondria, thus preventing the release of 
mitochondrial derived danger signals. Overall, these findings highlight 
Figure 1.5: Brucella interacts with the ER. After entry, virulent
intracellular Brucella resides within a vacuole (BCV) that interacts with early
endosomes. These early BCVs avoid further interactions with the endocytic
pathway and are in close contact with, the ER within the first hours after
infection (A). Vacuoles containing a attenuated strains fail to sustain
interactions with the ER (B) and ultimately fuse with lysosomes. This
schematic was adapted from Celli et al. J Exp Med, 2003. 198(4): p. 545-56.
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mechanisms by which context-dependent ER stress signals are relayed to 
mitochondria to promote or suppress inflammation, supporting the idea that the ER 
acts as a critical hub for integrating cellular stress and innate immune signaling.      
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Chapter 2 
Caspase-2 mediates a Brucella abortus RB51-induced hybrid cell death 
having features of apoptosis and pyroptosis 
(Published: Bronner DN et al (2013) Front Cell Infect Microbiol. doi: 
10.3389/fcimb.2013.00083) 
 
Abstract 
Programmed cell death (PCD) can play a crucial role in tuning the immune 
response to microbial infection. Although PCD can occur in different forms, all are 
mediated by a family of proteases called caspases. Caspase-2 is the most 
conserved caspase; however its function in cell death is ill-defined. Previously we 
demonstrated that live attenuated cattle vaccine strain Brucella abortus RB51 
induces caspase-2-mediated PCD of infected macrophages. However, the 
mechanism of caspase-2-mediated cell death pathway remained unclear. In this 
study, we found that caspase-2 mediated proinflammatory cell death of RB51-
infected macrophages and regulated many genes in different PCD pathways. We 
show that the activation of proapoptotic caspases-3 and -8 was dependent upon 
caspase-2. Caspase-2 regulated mitochondrial cytochrome c release and TNFα 
production, both of which are known to activate caspase-3 and caspase-8, 
respectively. In addition to TNFα, RB51-induced caspase-1 and IL-1β production 
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was also driven by caspase-2-mediated mitochondrial dysfunction. Interestingly, 
pore formation, a phenomenon commonly associated with caspase-1-mediated 
pyroptosis, occurred; however it did not contribute to RB51-induced 
proinflammatory cell death. Our data suggest that caspase-2 acts as an initiator 
caspase that mediates a novel RB51-induced hybrid cell death that simulates but 
differs from typical apoptosis and pyroptosis. The initiator role of the caspase-2-
mediated cell death was also conserved in cellular stress-induced cell death of 
macrophages treated with etoposide, naphthalene, or anti-Fas. Caspase-2 also 
regulated caspase-3 and -8 activation, as well as cell death in macrophages 
treated with each of the three reagents. Taken together, our data has 
demonstrated that caspase-2 can play an important role in mediating a 
proinflammatory response and a hybrid cell death that demonstrates features of 
both apoptosis and pyroptosis.  
Introduction 
Programmed cell death (PCD) is a crucial process initiated by the host in 
response to cellular stress and microbial infections. PCD can occur in a variety of 
ways [1]. Apoptosis, pyroptosis, and necroptosis are three pathways of PCD that 
can occur during microbial infections with substantially different outcomes. 
Apoptosis is a silent programmed cell death due to a lack of cytokine secretion [2]. 
Although the plasma membrane remains intact, apoptotic bodies can bleb off and 
be phagocytosed by other phagocytic cells in the surrounding area. Pyroptosis or 
“death by fire,” is inflammatory programmed cell death mediated by caspase-1 [3]. 
Caspase-1 processes proinflammatory cytokines (IL-1β and IL-18), and secretion 
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of these cytokines requires pore formation in the plasma membrane, which leads 
to cell swelling and eventually lysis. Necroptosis is a newly identified type of PCD 
that includes a proinflammatory response as well as loss of plasma membrane 
integrity [4]. In contrast to apoptosis and pyroptosis, serine/threonine kinases, 
RIP1 and RIP3, mediate necroptosis. In addition, necroptosis leads to the release 
of intracellular contents; mostly damage associated molecular patterns (DAMPs).  
Many microbes can induce cell death during infection and dissemination [5]. 
Avirulent Mycobacterium induces apoptosis in macrophages [6]. Neighboring 
uninfected macrophages, upon phagocytosis, killed Mycobacterium in apoptotic 
bodies released by Mycobacterium-infected macrophages. In addition, apoptotic 
blebs from bacterially infected cells induce a TH17 response. In contrast, Shigella 
and Salmonella-induced pyroptosis leads to the release and exposure of bacteria 
to reactive oxygen species (ROS) and neutrophils [7-9]. In addition to bacterial 
pathogens, parasitic and viral pathogens such as Trypanosoma cruzi and Vaccinia 
virus also have the ability to induce apoptosis and necroptosis respectively [10, 
11]. The outcomes of necroptosis are an increase in cytokine secretion and 
leukocyte infiltration as well as ROS production. As illustrated from previous 
studies, PCD can play an important role in controlling microbial infections. 
Meanwhile, many pathogens can inhibit these PCD pathways in various 
approaches. For example, virulent wild type Brucella strains typically inhibit PCD 
of infected macrophages [12-14]. Elucidating the PCD mechanism induced or 
inhibited by such pathogens is critical to uncovering mechanisms of pathogenesis, 
as well as protective immunity.  
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The main executors of the PCD process are caspases, which are divided 
into two groups: initiators and effectors. Initiator caspases activate effector 
caspases via cleavage whereas effector caspases initiate cell death by cleaving 
various downstream apoptotic proteins. C. elegans has a single caspase, Ced-3, 
that mediates all cell death. Of 13 caspases existing in mammalian systems, 
caspase-2 has the highest sequence homology with Ced-3 [15, 16]. Caspase-2 
plays important biological roles from oocyte development to aging control, and in 
intermediary development stages including DNA damage repair, tumor prevention, 
and infection control [17-20]. Caspase-2 can play different roles due to its unique 
domain structure, which resembles an initiator and effector caspase. It contains a 
caspase activation and recruitment domain (CARD) which is required for auto-
activation and binding to other molecules. Caspase-2 also contains a cleavage site 
[21] which resembles that of the effector caspase-3 [22]. These factors make the 
classification of caspase-2 difficult. Caspase-2-deficient mice develop without an 
overt phenotype although only mild apoptotic defects in oocyte and neuron 
developments were exhibited, suggesting that the function of caspase-2 is largely 
redundant for cellular homeostasis during development [23]. Caspase-2 has been 
shown to be instrumental in bacterial infections. Caspase-2 played a role in both 
caspase-1-dependent and -independent apoptosis of macrophages infected with 
Salmonella [24]. The various and often controversial roles of caspase-2 in different 
organisms and experimental conditions have been documented and discussed 
[25, 26].  The role of caspase-2 in regulating cell death and the exact mechanism 
remain unclear. 
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We previously demonstrated that rough attenuated Brucella abortus strain 
RB51 induces caspase-2-mediated apoptotic and necrotic cell death [13]. As a 
licensed cattle vaccine strain, RB51 is able to induce IFNγ and CD8+ T cell 
mediated cytotoxicity in mice [27]. Unlike its virulent counterparts, RB51 does not 
replicate in macrophages and induces robust caspase-2-mediated apoptotic and 
necrotic cell death [13]. In addition, RB51 induces cell death in dendritic cells [14]. 
However, the caspase-2-mediated RB51-induced cell death pathway is largely 
unknown. Previously, we showed that caspase-2 activation as well as decrease of 
the mitochondrial membrane potential occurred in dying macrophages infected 
with RB51 [13]. These characteristics would suggest that apoptosis via the 
mitochondria-driven intrinsic pathway was the cell death mechanism. We also 
showed that rough attenuated B. suis strain VTRS1 induces caspase-2-mediated 
proinflammatory cell death [12]. It is likely that RB51 also induces proinflammatory 
response that differs inherently from non-proinflammatory apoptosis. How RB51 
induces cell death remains unclear.      
Here we investigated which PCD mechanism was responsible for RB51-
induced cell death in macrophages. We found that RB51-infected macrophages 
exhibited mitochondrial dysfunction, activation of the caspase cascade (caspase-
3 and caspase-8), IL-1β and TNFα secretion, and pore formation in the plasma 
membrane – all of which were dependent upon caspase-2. In addition to infection, 
we found that caspase-2 also mediated cell death as well as caspase-3 and -8 
activation in macrophages treated with etoposide, naphthalene, and anti-Fas. 
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These results illustrate that RB51-induced caspase-2-mediated macrophage cell 
death is unique in that it exhibits characteristics of both apoptosis and pyroptosis.   
Results 
Caspase-2 mediates RB51-induced cell death via the extrinsic apoptosis pathway 
Our previous experiments using a chemical inhibitor and siRNA 
demonstrated that caspase-2 mediates RB51-induced macrophage cell death [13]. 
To confirm the caspase-2 mediated cell death, wild type (WT) and caspase-2 
deficient (casp2-/-) bone-marrow derived macrophages (BMDMs) were infected 
with RB51, and cell death was assessed by Annexin V/propidium iodide (PI) 
staining and lactate dehydrogenase (LDH) release. Cell death was abolished in 
casp2-/- BMDM (Fig. A1A-B) which confirms that caspase-2 is required for RB51 
induced cell death. We assessed if there was any difference in RB51 intracellular 
behavior by measuring CFU throughout infection. We found that casp2-/- BMDM 
were able to kill RB51 just as efficiently as WT BMDM (Fig. A1C). Therefore, any 
differences in initiating cell death were not due to lack of infectivity or bacterial 
killing in casp2-/- BMDMs.  
Since caspase-2 is required for RB51 induced cell death, we assessed 
which PCD pathway caspase-2 was mediating RB51-induced cell death. Inhibition 
of caspase-3 and/or caspase-8 activity led to a decrease in cell death; however, it 
was not as significant as caspase-2 deficiency (Table 2.1). Inhibition of caspase-3 
or -8 in RB51-infected macrophages resulted in 57.3 ± 2.1% and 65.7 ± 3.7% cell 
death, respectively (P-value <0.001) (Table 2.1). Inhibition of both caspase-3 and 
Table 2.1: Cell death measurements in casp2 deficient and caspase-3 and -
8 inhibited macrophages. Percent ± SD of n≥3 independent experiments. Cells
were counted in randomly selected fields of 100 cells. All conditions except
untreated where in the presence of RB51 (MOI 200).
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-8 led to only 36.3 ± 2.5% cell death, suggesting the two types of inhibitions are 
synergistic. These data suggest that RB51-induced cell death may involve the 
apoptotic pathways associated with caspase-3 and caspase-8.  
Classically, caspase-3 and caspase-8 are linked to intrinsic (intracellular 
signal driven) and extrinsic (death receptor driven) apoptotic pathways 
respectively [2]. Both pathways are linked to caspase-2 by mediating mitochondrial 
cytochrome c release and caspase-8 activation [28, 29]. To assess if caspase-2 
regulated these pathways during RB51 infection, we investigated caspase-3 and 
caspase-8 activation in WT and casp2-/- BMDMs by measuring cleavage. The 
cleavage of both caspase-3 and caspase-8 was abolished in RB51-infected casp2-
/- BMDMs (Fig. 2.1A). Inhibition of caspase-3 and -8 did not affect caspase-2 
activation (Fig. A2A-B). Previous studies illustrated that both the intrinsic and 
extrinsic cell death pathways can propagate signaling by inducing mitochondrial 
dysfunction, which eventually leads to cell death. Therefore, we investigated if 
caspase-2 mediated mitochondrial dysfunction in RB51-infected macrophages. 
Previously we observed that in RB51-infected macrophages, mitochondrial 
membrane potential decreased over time, suggesting that mitochondrial 
cytochrome c release (a marker of mitochondrial dysfunction) occurs. We found 
that in WT BMDMs, cytochrome c release increased throughout infection, however 
in casp2-/- BMDMs cytochrome c release was abolished (Fig. 2.1A).  
To assess if mitochondrial dysfunction contributed to RB51-induced cell 
death, the cytochrome c release was blocked with cyclosporin A (CsA) in RB51-
infected RAW264.7 (murine) macrophages. CsA prevents opening of the 
Figure 2.1: Caspase-2 drives both the intrinsic and extrinsic cell death
pathways. (A) caspase-3 and -8 cleavage (activation) as well as cytochrome c
(cyto c) release in RB51-infected WT and casp2-/- BMDMs. β-actin serves as a
loading control. UT and ET represent untreated and etoposide (25 µM, 6hr
treatment) respectively. Immunoblots are representatives of n≥3 independent
experiments. (B) LDH release in RB51-infected RAW264.7 macrophages in the
presence of cyclosporin A (CsA; inhibitor of mitochondrial permeability transition
pore, 10 μM) and Anti-TNFα (10 µg/mL). Error bars represent mean ± SD of n≥3
independent experiments. **p < 0.001 and ***p < 0.0001, Student’s t-test. n.s. =
not significant. Immunoblots are representatives of n≥3 independent
experiments.
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mitochondrial permeability transition pore (MPTP), a pore responsible for the 
release of mitochondrial contents such as cytochrome c [30]. In the presence of 
CsA, cell death was significantly reduced (p<0.0001) in RB51-infected 
macrophages (Fig. 2.1B). Seeing that mitochondrial dysfunction occurs and both 
caspase-3 and caspase-8 are activated, we explored if RB51-induced cell death 
was acting through the extrinsic pathway. Extrinsic or death receptor mediated cell 
death can be activated by Fas ligand (FasL) and TNFα. Since live attenuated B. 
suis strain VTRS1 induces a proinflammatory response [12], we investigated if 
TNFα played a role in mediating RB51-induced cell death. We treated RAW264.7 
macrophages with anti-TNFα and assessed cell death via LDH release. Anti-TNFα 
treatment led to a decrease in LDH release when compared to untreated RB51-
infected RAW264.7 macrophages (Fig. 2.1B, 85.5±5.1% vs. 21.4±6.5% 
respectively). These observations suggest that caspase-2 drives the extrinsic cell 
death pathway in RB51-infected macrophages.  
Caspase-2 regulates caspase-1 activation and IL-1β production in RB51-infected 
macrophages  
Studies have illustrated that a proinflammatory response can be the trigger 
or product of cell death [2, 3]. Since TNFα played a role in RB51-induced cell 
death, we assessed if caspase-2 mediated TNFα production. Over time, TNFα 
levels increased in RB51-infected WT BMDMs. However, in casp2-/- BMDMs, 
TNFα was reduced to untreated levels (Fig. 2.2A). In addition, CsA treatment led 
to a decrease in TNFα production. 
Figure 2.2: Caspase-2 drives proinflammatory responses in RB51-infected
macrophages. (A) TNFα and (B) IL-1β levels in WT, casp2-/-, CsA (cyclosporin
A, inhibitor of mitochondrial permeability transition pore, 10 μM) and Z-WEHD-
FMK (caspase-1 inhibitor, 20 µM) treated BMDMs. Error bars represent mean ±
SD of n≥3 independent experiments. ‡,*p < 0.01 and ‡‡‡, ***p < 0.0001,
Student’s t-test. (*,***) and (‡, ‡‡‡) represent comparison to untreated and WT +
RB51 respectively. (C) caspase-1 cleavage (activation) in RB51-infected WT
and casp2-/- BMDMs. UT represents untreated (negative control). Immunoblots
are representatives of n≥3 independent experiments.
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Another cytokine associated with proinflammatory cell death is IL-1β. 
During pyroptosis, caspase-1 processes IL-1β and aids in its secretion. 
Interestingly, caspase-2 contains a CARD domain and has been shown to mediate 
caspase-1 activation during Salmonella infections [24]. Similar to TNFα, IL-1β 
levels increased above untreated levels starting at 6 h.p.i. however, in casp2-/- and 
caspase-1 inhibited BMDMs, IL-1β production was abolished (Fig. 2.2B). In the 
presence of CsA, IL-1β levels were significantly reduced in RB51-infected 
macrophages. A decrease in IL-1β levels in casp2-/- BMDMs suggested that either 
caspase-2 regulates caspase-1 activation or caspase-2 is directly responsible for 
the processing of IL-1β. To evaluate these two possibilities, caspase-1 cleavage 
in RB51-infected WT and casp2-/- BMDMs was measured. RB51 induced caspase-
1 cleavage in WT BMDMs starting at 6 h.p.i.; however, cleaved caspase-1 was 
absent in casp2-/- BMDMs (Fig. 2.2C). These data suggest that caspase-2, via 
mitochondrial dysfunction, mediates caspase-1 activation and IL-1β production in 
RB51-infected macrophages.  
Pore formation is not required for RB51-induced cell death 
Caspase-1 activation and IL-1β production are key indicators of pyroptosis. 
During pyroptosis, pores form in the plasma membrane, leading to a change in 
ionic gradient and water influx. The consequence of the pores is cell swelling, due 
to water influx, and eventually cell lysis. Salmonella enterica serovar Typhimurium 
SL1344 is a pathogen known for inducing pyroptosis in macrophages [31]. We 
hypothesized that RB51 induced pore formation in macrophages. To test this, 
RB51-infected RAW264.7 macrophages were stained with two membrane 
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impermeant dyes, ethidium bromide (EtBr, 394 Da) and the larger sized ethidium 
homodimer-2 (EthD2, 1293 Da). Uptake of EtBr and EthD2 would represent 
discrete pore formation and loss of plasma membrane integrity respectively. 
Gliotoxin (apoptosis inducer) treated RAW264.7 macrophages excluded both 
impermeant dyes (Fig. 2.3A), indicative of an intact plasma membrane. In RB51-
infected WT BMDMs, uptake of EtBr began at 1 h.p.i. and increased throughout 
infection (Fig. 2.3A). Uptake of EthD2 was significantly less than EtBr and did not 
occur until 6 h.p.i. in RB51-infected macrophages (Fig. 2.3A). Since pore formation 
has been shown to be dependent upon caspase-1, it was not surprising to see that 
uptake of both EtBr and EthD2 were abolished in RB51-infected casp2-/- and 
caspase-1 inhibited WT BMDMs (Fig. 2.4A and Fig. A3).  
We further assessed if pore formation in RB51-infected macrophages 
contributed to RB51-induced cell death. RB51-infected macrophages were treated 
with glycine, a cytoprotective agent. Glycine prevents cell death by stabilizing the 
ion gradient [32]. Glycine treatment decreased SL1344-induced macrophage cell 
death however, no effect was seen with RB51 (Fig. 2.3B). These findings 
demonstrate that although pore formation occurs in RB51-infected macrophages, 
it is not the cause of the RB51-induced macrophage cell death.  
Caspase-2 mediates cell death in other contexts 
Since caspase-2 can regulate cell death in the context of a Brucella 
infection, we investigated if caspase-2 also plays a critical role in the presence of 
different cell death chemical inducers – etoposide, naphthalene, anti-Fas, and 
gliotoxin. Etoposide and naphthalene are DNA damaging agents that trigger 
Figure 2.3: Pore formation does not contribute to RB51-induced cell death.
(A) WT and casp2-/- BMDMs treated with Gliotoxin (10 µM, 6 hr treatment) or
infected with RB51 were stained with the membrane permeable dye Hoechst
33342 (blue) and the membrane impermeant dyes (red), EtBr (MW 394) or EthD2
(MW 1293). Adherent cells were visualized by fluorescence microscopy (100x).
Images are representatives of n≥3 independent experiments. (B) LDH release in
RB51 and SL1344-infected RAW264.7 macrophages in the absence or presence
of glycine (5mM). Error bars represent mean ± SD of n≥3 independent
experiments. **p < 0.001 and ***p < 0.0001, Student’s t-test. n.s. = not significant.
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mitochondrial ROS production, inducing cell death via the intrinsic pathway [33-
36]. Treatment with anti-Fas antibody mimics activation of death receptor signaling 
by Fas ligand through the extrinsic pathway. [37]. Gliotoxin mediates Bak activation 
leading to cytochrome c release from the mitochondria and cell death [38]. To 
assess the role of caspase-2 in the presence of these chemical inducers, we first 
assessed caspase-2 activation. In macrophages treated with etoposide, 
naphthalene, and anti-Fas, caspase-2 was activated. However, gliotoxin did not 
induce caspase-2 activation (Fig. 2.4A). Next, we investigated if caspase-2 
mediated cell death in the presence of these inducers via Annexin V/PI staining. 
All four chemicals induced cell death after 6 hr of treatment. The caspase-2 
deficiency led to a significant decrease in cell death in etoposide, naphthalene, 
and anti-Fas treated but not gliotoxin treated macrophages (Fig. 2.4B).  
Knowing the mechanism by which these chemical inducers mediate cell 
death, we assessed whether caspase-3 and -8 activation occurred and whether 
caspase-2 mediated their activation as seen in RB51-infected macrophages. 
Caspase-3 was activated in etoposide, naphthalene, anti-Fas, and gliotoxin 
treated WT BMDMs (Fig. 2.4C). Caspase-3 activation was abolished in casp2-/- 
BMDMs treated with etoposide, naphthalene, and anti-Fas but not gliotoxin. 
Caspase-8 activation was observed in etoposide, naphthalene, and anti-Fas 
treatment yet absent during gliotoxin treatment (Fig. 2.4C). Similar to caspase-3, 
caspase-8 activation was abolished in etoposide, naphthalene, anti-Fas treated 
casp2-/- BMDMs. These data indicate that caspase-2 can exhibit a crucial role in 
mediating cell death initiated by other stimuli besides microbial infection.  
Figure 2.4: Caspase-2 can also mediate caspase-3 and -8 activation in
other contexts. (A) Caspase-2 cleavage (activation) in RB51-infected
RAW264.7 macrophages. UT, ET, NT, α-Fas, and GT represent untreated,
etoposide (25 µM, 6hr treatment), Naphthalene (100 µM, 6hr treatment), Anti-Fas
(1 µg/mL, 6h4 treatment), and Gliotoxin (10 µM, 6hr treatment) respectively. (B)
ET, NT, α-Fas, GT treated WT and casp2-/- BMDMs were stained with Annexin
V/propidium iodide (PI). Adherent cells were visualized by fluorescence
microscopy (100x). Cells were counted in randomly selected fields of 100 cells.
Images are representatives of n≥3 independent experiments. (C) Caspase-3 and
-8 cleavage (activation) in ET, NT, α-Fas, GT treated WT and casp2-/- BMDMs.
Immunoblots are representatives of n≥3 independent experiments.
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Conclusions 
Here we report that RB51-induced cell death is driven by the caspase-
2/mitochondrial axis. Our results demonstrated that RB51-infected macrophages 
induce the caspase-2 activation, and the activated caspase-2 mediates caspase-
1, -3 and -8 activations, and TNFα and IL-1β secretions. Mitochondrial release of 
cytochrome c was associated with caspase-3 activation and contributed to RB51-
induced cell death. Although pores formed in the plasma membrane upon 
infection, they did not contribute to cell death. In addition to cell death, we showed 
that the RB51-induced proinflammatory response was mediated by caspase-2 and 
mitochondrial dysfunction. In addition to microbial infections, caspase-2 also 
demonstrated a contributing role in mediating cell death with different cell death 
inducers.  
Rough Brucella species are known to induce cell death as well as a robust 
immune response. Here we show that proinflammatory cytokine TNFα plays a role 
in RB51-induced macrophage cell death; however, in the case of CA180, another 
B. abortus rough strain, this is not the case [39]. Although both RB51 and CA180 
belong to the same genus and share a rough LPS phenotype, there are striking 
differences in their LPS. Both RB51 and CA180 lack an O-antigen on their LPS 
however, CA180 has a truncated core polysaccharide due to a mutation in the 
phosphomannomutase gene [40]. Phosphomannomutase is needed to the 
elongation of the polysaccharide core. The polysaccharide core has been shown 
to elicit cytokine production, any changes (e.g. shortening) can decrease cytokine 
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production [41, 42]. Therefore, unlike RB51, CA180 may not elicit strong TNFα 
production, which may explain the differences in TNFα dependent cell death.  
Although caspase-2 has been linked to many different cellular processes, 
caspase-2 is still considered primarily a proapoptotic caspase. Here we show that 
caspase-2 can mediate IL-1β production, as well as caspase-1 activation. In 
addition to Brucella infection, caspase-2 has also been shown to regulate caspase-
1 activation in Salmonella infected macrophages. We speculate that caspase-2 
might regulate caspase-1 by interacting with the inflammasome complexes 
responsible for caspase-1 activation or by inducing an inflammasome trigger (e.g. 
ER stress, mitochondrial DNA release, or ROS production). Caspase-1 interacts 
with different inflammasome proteins and accessory proteins via its CARD domain. 
Inflammatory caspases (caspase-1, -4, -5, -11) interact with inflammasome and 
accessory proteins via their CARD domain. Caspase-2 also contains a CARD 
domain. Further investigation into whether caspase-2 can interact with different 
inflammasome components is needed. Another possible mechanism for caspase-
2 regulation of caspase-1 activation is through mitochondrial dysfunction. As seen 
with CsA treatment, there was a sharp decrease in IL-1β production suggesting 
that the mitochondria can aid in inflammasome activation during RB51 infection. 
Recent studies have linked NLRP3 and AIM2 activation to mitochondrial 
dysfunction [43-45]. It is possible that caspase-2-induced mitochondrial 
dysfunction leads to release of mitochondrial danger associated molecular 
patterns (DAMPs). Mitochondrial DAMPs (e.g. mtDNA or cardiolipin exposure) can 
lead to NLRP3 and AIM2 inflammasome activation [44]. Caspase-2 has been 
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linked to mediating mitochondrial dysfunction – caspase-2 cleaves Bid leading to 
mitochondrial outer membrane pore formation and eventually release of 
mitochondrial content (e.g. cytochrome c). Whether caspase-2-mediated release 
of mitochondrial DAMPs is the mechanism by which the inflammasome and 
caspase-1 activation occurs remains to be elucidated.  
The caspase-2-mediated cell death pathway seen in RB51-infected 
macrophages differs from classical apoptosis, pyroptosis, and necroptosis (Table 
2). RB51-induced cell death is not mediated by caspase-1. Our data suggest that 
RIP1 and RIP3 (mediators of necroptosis) are not active because both caspase-2 
and -8 activated by RB51 infection can cleave RIP1 and RIP3 – the cleavage of 
these two prevents necroptosis from occurring [46, 47]. In addition, RB51-infected 
macrophages secrete proinflammatory cytokines starting at 6 h.p.i., a 
characteristic absent in apoptosis. Caspase-1 is active and contributes to IL-1β 
production. However, unlike the phenomenon seen in pyroptosis, neither caspase-
1 nor the pore in the plasma membrane contributes to cell death. Our data suggest 
that RB51-induced caspase-2-mediated cell death does not fall into any of the 
three classical programmed cell death pathways. Owing to the common feature of 
caspase-mediated proinflammatory cell death between caspase-1-mediated 
pyroptosis and caspase-2-mediated cell death, previously we tentatively labeled 
the caspase-2-mediated proinflammatory cell death as “caspase-2-mediated 
pyroptosis” [12]. Considering that current study also clearly shows that caspase-2 
also mediates apoptosis-like features (e.g., caspase-3 and -8 activation and loss 
of mitochondrial membrane potential) (Table 2.2), caspase-2 appears to mediate 
Table 2.2: Comparison of caspase-2-mediated cell death to classical
apoptosis and pyroptosis. +: occurs, -: does not occur, +/-: may occur but
not required, ? = unknown.
50
15  
 
a hybrid cell death that includes partial features of both apoptosis and pyroptosis. 
Although distinct, caspase-2-mediated cell death and necroptosis appear to share 
some similarities as well (Table 4.2).  
Our studies on the relationship between caspase-2 and cell death induced 
by different cell death inducers further illustrate the critical role and the mechanism 
of caspase-2 in triggering PCD. Both etoposide and naphthalene are DNA damage 
inducers, a stimulus known for activating caspase-2. Interestingly, both etoposide 
and naphthalene induced caspase-8 activation. Previous studies have illustrated 
a connection between DNA damage, caspase-8, and caspase-2. Both caspase-2 
and caspase-8 can be activated by p53 [48, 49]; this suggests that upon etoposide 
and naphthalene treatment, p53 activates caspase-2 leading to caspase-8 
activation. Anti-Fas works through the extrinsic pathway and leads to cell death via 
caspase-8 dependent activation of caspase-3. Seeing that caspase-2 aided in 
caspase-8 activation (outside of DNA damage) clearly suggests that caspase-2 
can act as an initiator caspase to mediate activation of other caspases. Whether 
caspase-2 mediates caspase-8 activation directly or indirectly remains unclear. 
Gliotoxin induced cell death via the intrinsic pathway. Only caspase-3 was 
activated in gliotoxin-treated macrophages. Cytochrome c can aid in caspase-2 
activation however [50], in the context of gliotoxin intoxication this was not the case 
because caspase-2 activation did not occur. Gliotoxin acts on Bak and its 
downstream target t-Bid (a known target cleaved by caspase-2, [28]); therefore, it 
is possible that gliotoxin short-circuits the classical intrinsic pathway and does not 
require signaling components upstream of the mitochondria. In the case of 
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etoposide and naphthalene, the data suggest that caspase-2 regulates caspase-3 
activation via the mitochondria. Caspase-3 is activated via the apoptosome, a 
multiprotein complex dependent upon cytochrome c release. Caspase-2 was 
previously reported to act upstream of caspase-8 during ceramide-induced 
mitochondrial apoptosis in T cells [29]. It appears that the caspase-2 regulation of 
caspase-3 and -8 can occur in different cell types with different treatments, so this 
type of regulation is neither cell specific nor context specific. These observations 
suggest that caspase-2 can play a critical role in initiating programmed cell death. 
The caspase-2-mediated cell death pathway is likely critical to microbial 
pathogenesis and host immunity. In the context of RB51, cell death and the 
proinflammatory response may have synergistic effects on host immune 
responses. Cell death may result in the exposure of RB51 to a more hostile 
extracellular environment (as seen in pyroptosis and necroptosis). In addition, 
neighboring macrophages and dendritic cells may recognize processed RB51 
antigens leading to cross priming of CD8+ T cells (important for RB51-induced 
protective immunity). We recently showed that RB51 induced cell death in bone 
marrow derived dendritic cells and aided in maturation as well as priming of T cells 
– all of which were dependent upon caspase-2 [14]. These observations 
demonstrate the importance for caspase-2, as well as cell death, in initiating the 
immune response. Utilizing this programmed cell death pathway may ensure that 
the host triggers a potent immune response. Prevention of this pathway may aid 
in enhancing survival of virulent Brucella in macrophages. Our previous work 
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suggested prevention – virulent strain B. abortus S2308 did not induce caspase-2 
activation nor cytochrome c release in infected macrophages [13].  
Caspase-2 is also implicated in other processes (cancer regulation and 
metabolism) and may take on a regulatory role in these processes as well. We 
have made an original observation that caspase-2 plays a non-redundant role in 
triggering the proinflammatory cell death of RB51-infected macrophages and in 
macrophages treated with various drugs. After the evolution of complex caspase-
cascade cell death signaling pathways in advanced animals, it is suggestive that 
the protein functions of the highly conserved caspase-2 have been preserved 
during evolution and serve as safeguards to regulate various cell death pathways. 
It is likely that intracellular pathogens with similar lifestyles to Brucella (e.g., 
Salmonella, Mycobacterium, Listeria, and Legionella) may utilize caspase-2 during 
infection. Further understanding of caspase-2-mediated pyroptosis can aid in 
supplying a blueprint for effective brucellosis vaccines (both animals & humans) 
as well as effective therapeutics against cancers and other diseases.  
Materials and Methods 
Mice 
The caspase-2 knockout (Casp2KO) mice were originally generated by Junying 
Yuan and kindly provided by Dr. Brian Herman of the University of Texas Health 
Science Center at San Antonio with Dr. Yuan's consent [23]. The deletion 
inactivates both the long and short form of caspase-2. The mice were backcrossed 
with C57BL/6 once in the Unit for Laboratory Animal Medicine at the University of 
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Michigan Medical School, and then used as founders. Casp2KO and wild type 
C57BL/6 (Jackson) mice with similar ages were applied in the experiments. The 
University Committee on Use and Care of Animals (UCUCA) at the University of 
Michigan approved the protocol (#09695) to use mice for studies described here. 
Bacterial strains and reagents 
RAW264.7 macrophages and bone marrow derived macrophages (BMDMs) were 
infected with Brucella abortus strain RB51 (from Dr. G. Schurig, Virginia 
Polytechnic Institute and State University) and Salmonella typhimurium SL1344 
(from Mary O’Riordan, University of Michigan). The following inhibitors and 
inducers were used: cyclosporin A (Sigma-Aldrich), etoposide (Sigma-Aldrich), 
naphthalene (Sigma-Aldrich), Anti-Fas (BioVision), gliotoxin (-Aldrich), glycine 
(Sigma-Aldrich), Z-WEHD-FMK (Caspase-1 inhibitor, R&D Systems), Z-DEVD-
FMK (Caspase-3 inhibitor, R&D Systems), Z-IETD-FMK (Caspase-8 inhibitor, 
R&D Systems), and anti-TNFα (mouse specific, BioVision). 
The following antibodies were used: anti-cytochrome c (cat#:4272S, Cell 
Signaling), anti-caspase-3 (cat#: 9662S, Cell Signaling), anti-caspase-8 (cat#: 
4927S, Cell Signaling), anti-caspase-2 (cat#: 3027-100, BioVision), anti-caspase-
1 (cat#: sc-514, Santa Cruz), and anti-actin (cat#: MS1295P1, Thermo Scientific).  
Cell culture and infection 
BMDMs were isolated from WT and casp2-/- mice on a C57BL/6 background. 
Isolated BMDMs were differentiated in DMEM (GIBCO) supplemented with 20% 
heat-inactivated FBS (GIBCO), 1% L-glutamine (200 mM), 1% sodium pyruvate 
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(100 mM), 0.1% β-mercaptoethanol (55 mM) , and 30% L-929 fibroblast 
conditioned medium. BMDMs were cultured in non-TC treated plates, fed fresh 
media on day 3, and harvested on day 6. BMDMs were maintained at 37°C under 
5% CO2.  
Four million RAW264.7 macrophages and BMDMs were seeded in 6 well plates 
18 hr prior to infection. The following day, where indicated cells were pretreated 
with cyclosporin A (10 μM), Z-WEHD-FMK (20 μM), Z-DEVD-FMK (20 μM), Z-
IETD-FMK (20 μM) and Anti-TNFα (10 μg/mL) for 1 hr prior to infection. Untreated 
and pretreated cells were infected with RB51 (MOI 200) or SL1344 (MOI 25) for 
30 min, after which the inoculum was removed and cells were washed with PBS. 
Medium containing 50 µg/ml of gentamicin was added to kill extracellular bacteria. 
To synchronize infection, cells were spun at 1200 rpm for 3 min after adding 
inoculum. Cells were treated with etoposide (25 μM), naphthalene (100 μM), anti-
Fas (1 μg/mL), and gliotoxin (10 μM) for 6 hr. At the indicated times, cells were 
lysed in buffer containing 1% NP-40 on ice for 15 min and spun at 13,000 rpm for 
15 min to pellet the insoluble fraction. Soluble fractions were used for immunoblot 
assays.  
Immunoblot Assay 
Cytosolic extracts collected at various time points (1, 6, and 24h pi) were separated 
by SDS-PAGE, transferred to PVDF membranes (Millipore), blocked with 5% milk 
in TBS-Tween20 (TBS-T), and incubated overnight at 4°C with primary antibodies 
stated above. Membranes were washed with TBS-T and incubated with secondary 
HRP conjugated to either goat anti-rabbit IgG (cat#: 12-348, Millipore) or goat anti-
56 
 
mouse IgG (cat#: 1034-05, Southern Biotech) at room temperature for 1 hr. Bands 
were visualized using the ECL Western Blotting Substrate Kit (Pierce). 
Immunoblots in the figures are representative of n≥3 independent experiments. 
Cytokine Detection 
Culture supernatants were collected at different time points (1, 6, and 24h pi) from 
macrophages infected as described above. IL-1β and TNFα levels were 
determined by sandwich enzyme-linked immunosorbent assay (ELISA) according 
to manufacturer’s instructions (BioLegend). A minimum of three technical 
replicates per experiment and three experimental replicates were analyzed for 
each condition. 
Cell Death Assay 
RAW264.7 macrophages were seeded in 6 well plates at a concentration 9.6 X 104 
per well and infected with RB51 as stated above. Cells were stained with Annexin 
V and propidium iodide (PI) using the Annexin V-FLUOS staining kit (Roche 
Diagnostics Corporation). Cells were washed with PBS and incubated with the 
fluorescent dyes for 15 min in the dark at room temperature. Fluorescence was 
observed with a Nikon TK-2000-S microscope and photographed with a RT Slide 
Spot digital camera and QCapture Pro software. Uninfected macrophages served 
as negative controls. 
Ethidium bromide (EtBr) and Ethidium homodimer-2 (EthD2) staining 
Macrophages were grown in 6-well plates and infected as described above. At 
different time points post infection, cells were washed with PBS (GIBCO) and 
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stained with Hoechst 33342 (5 μg/mL) and either EtBr or EthD2 (25 μg/mL) 
according to the manufacturer’s instructions. Cell were analyzed with a Nikon TK-
2000-s microscope and photographed with a RT slide spot digital camera and 
QCapture Pro Software. 
Lactate dehydrogenase (LDH) Release Assay 
Macrophages were seeded in 96-well plates and infected with RB51 or SL1344 as 
stated above. Supernatants were analyzed for the presence of LDH enzyme using 
the CytoTox-ONE™ Homogeneous Membrane Integrity Assay (Promega) as 
directed by the manufacturer’s instructions. Percentage of LDH release was 
calculated as 100 X [(Experimental LDH Release - Culture Medium 
Background)/(Maximum LDH Release – Culture Medium Background)]. 
Statistical Analysis  
All p values were generated between identified samples using unpaired two-tailed 
Student’s t-tests and represent analysis of ≥3 replicates per condition. ‡,*p<0.01 
‡‡,**p<0.001 and ‡‡‡,***p<0.0001. 
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Chapter 3 
ER stress activates the inflammasome via NLRP3-caspse-2 driven 
mitochondrial damage 
Abstract 
Endoplasmic reticulum (ER) stress is observed in many human diseases, often 
associated with inflammation. ER stress can trigger inflammation through NLRP3, 
which may stimulate inflammasome formation by association with damaged 
mitochondria. How ER stress triggers mitochondrial dysfunction and 
inflammasome activation is ill defined. Here we use an infection model to show 
that the IRE1ER stress sensor regulates mitochondrial dysfunction through an 
NLRP3-mediated feed-forward loop, independently of ASC. IRE1 activation 
increased mitochondrial reactive oxygen species, promoting NLRP3 association 
with mitochondria. NLRP3 was required for ER stress-induced cleavage of 
caspase-2 and Bid, and subsequent release of mitochondrial contents.  Caspase-
2 and Bid were necessary for activation of the canonical inflammasome by 
infection-associated or sterile ER stress. These data identify an NLRP3-caspase-
2 dependent mechanism that relays ER stress to the mitochondria to promote 
inflammation, integrating cellular stress and innate immunity.   
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Introduction 
Cellular stress provokes release of molecular danger signals that stimulate 
inflammatory signaling [1, 2], but the mechanisms linking stress with release of 
danger associated molecular patterns (DAMPs) are not fully defined.  Such 
mechanisms are highly relevant to human health as molecular stress and 
inflammation increase with age and are associated with many acute and chronic 
diseases [3-6]. Mitochondria can act as platforms to nucleate signaling by large 
molecular complexes, like the NLRP3 inflammasome, and drive inflammation 
through release of mitochondrial DAMPs in response to diverse stressors [7]. How 
such different stressors as infection, glucose deprivation, oxidative stress, or 
disruption of calcium homeostasis trigger these inflammatory events is not fully 
understood. The endoplasmic reticulum (ER) is a large endomembrane 
compartment that is highly sensitive to perturbation and is central to the function 
of many organelle networks, suggesting that ER may act as a relay station 
between stressors and the mitochondria, linking stress and inflammatory signaling.   
Three ER-resident unfolded protein sensors ATF6, IRE1 (IRE1), and PERK 
control the ER stress response, an adaptive program that defines the fate of the 
stressed cell [8]. Toll-like receptors (TLR), which primarily recognize microbial 
ligands like lipopolysaccharide (LPS), selectively stimulate ER stress sensors [9], 
and LPS-primed macrophages react to ER stress by activating the NLRP3 
inflammasome [10]. Microbial infection represents a useful model for investigating 
ER stress and inflammation because infection is often associated with ER stress, 
and animals deficient in components of the IRE1 signaling pathway are more 
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susceptible to bacterial infection than controls [9, 11-13]. Brucella abortus strain 
RB51 is an attenuated bacterial vaccine strain that infects macrophages, causes 
ER stress, and provokes a robust immune response without the complex effects 
of intracellular replication [14]. We therefore used RB51 as a probe to elucidate 
ER stress-dependent immune signaling. Virulent B. abortus mediates 
inflammasome activation through NLRP3 [15], a sensor responsive to diverse 
cellular stresses, suggesting that B. abortus strains could be appropriate for 
studying the interplay between ER stress and NLRP3-dependent immune 
signaling [4]. NLRP3-deficient animals exhibit increased susceptibility and 
decreased survival during infection by some microbial pathogens [16]. Notably, 
NLRP3 in a resting state is associated with ER, but upon stimulation moves to ER-
mitochondrial junctions [17]. These data led us to hypothesize that ER stress 
sensors could modulate NLRP3-dependent crosstalk between ER and 
mitochondria leading to inflammasome activation.   
Results 
RB51-induced inflammasome activation requires IRE1 and TXNIP 
 TLR ligands (e.g., LPS) activate IRE1, but not ATF6 or PERK, activating 
transcription of proinflammatory cytokines [9]. To determine if IRE1 was stimulated 
during RB51 infection, we investigated splicing of xbp1 transcript, a direct target of 
the endonuclease domain of activated IRE1 [8]. Tunicamycin (TM), an inhibitor of 
protein glycosylation [8, 18], served as a positive control for ER stress assays. 
Robust splicing of xbp1 was seen in tunicamycin-treated bone marrow derived 
macrophages (BMDM) as well RB51-infected BMDM at 8h post-infection (pi) (Fig. 
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3.1A). ER stress signaling can lead to cell death in some contexts, so we measured 
release of the large cytosolic lactate dehydrogenase complex as a measure of cell 
death and found that the majority of infected cells remained viable by 8h post 
infection (Fig A4A). Thus, infection by RB51 stimulated IRE1 activation, as 
previously observed for other microbial ligands [9].   
Recent studies revealed that ER stress induced by metabolic perturbation 
could mediate inflammasome activation [19]. In addition, RB51 stimulates robust 
IL-1β production at both low and high multiplicity of infection (Fig. A4B). We 
therefore tested whether ER stress was also required for RB51-induced IL-1β 
production. We infected BMDM with RB51 in the presence of 4µ8C, an inhibitor of 
the IRE1 endonuclease [20]. Treatment with 4µ8C led to a decrease in caspase-1 
cleavage, but not in bacterial uptake. (Fig. 3.1B and Fig. A5). Treatment with 
tauroursodeoxycholic acid (TUDCA), a molecular chaperone that alleviates ER 
stress, or 4µ8C, led to a significant decrease in IL-1β production in RB51-infected 
BMDM, but not BMDM treated with LPS+ATP (L+A), our positive control condition 
for inflammasome activation assays (Fig. 3.1C). IRE1 inhibition had no effect on 
L+A-induced caspase-1 cleavage and IL-1β production. These data suggest that 
unlike RB51, L+A does not rely on IRE1 to induce IL-1β production. Knockdown of 
IRE1 (IRE1KD, Fig. A6A and B) similarly resulted in decreased IL-1β production 
and caspase-1 cleavage.  
To determine whether IRE1 plays a role in modulating inflammation in vivo, 
we treated C57BL/6 mice with either 5% DMSO (vehicle control) or 4µ8C and 
infected the animals intraperitoneally with 108 CFU of RB51. Consistent with our 
Figure 3.1: IRE1 via TXNIP modulates RB51-induced inflammasome
activation. (A) xbp1 splicing, in RB51-infected BMDM. qRT-PCR samples were
treated with PstI to distinguish between spliced (184 bp) and unspliced variants
(119 bp following PstI digestion). (B) Caspase-1 cleavage in RB51-infected
BMDM in absence or presence of 4µ8c. (C) IL-1β ELISA analysis of
supernatants from RB51-infected BMDM treated with or without TUDCA
(chemical chaperone, 300 µM) and 4µ8c (IRE1 inhibitor, 50 µM). Error bars
represent mean ± SD of n≥3 independent experiments. *** represent p-value
<0.0001, n.s. = not significant. (D) Serum IL-1β levels in mice treated with 5%
DMSO (control, n = 15) or 4µ8c (n = 15) and infected with RB51 (i.p., CFU 1 x
108). (E) qPCR analysis of IL-1β transcript levels RB51-infected BMDM in
absence or presence of 4µ8c. IL-1β ELISA analysis of supernatants from RB51-
infected BMDM transfected with (F) non-target and xbp1 siRNA or (G) non-
target and TXNIP siRNA. (H) CM-H2DCFGA was used to measure ROS levels
during RB51 infection in presence of 4µ8c or TXNIP siRNA. UNT, TM, and L+A
represent untreated, tunicamycin (10 µg/mL, positive control for ER stress
activation) and LPS+ATP (200 ng/mL and 1mM respectively; positive control for
inflammasome activation).
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in vitro findings, 4µ8C-treated mice showed significantly decreased serum IL-1β, 
as well as increased bacterial burden in the spleen (Fig. 3.1D and Fig. A7). These 
data point to IRE1 as an important regulator of ER stress-induced inflammasome 
activation during infection.  
Previous studies have identified multiple targets for the IRE1 endonuclease, 
including xbp1 and miR-17, a negative regulator of thioredoxin-interacting protein 
(TXNIP) translation. The XBP1 transcription factor selectively enhances 
transcription of pro-inflammatory cytokine genes. IRE1-dependent miR-17 
degradation increases TXNIP protein, which shuttles to the mitochondria and binds 
thioredoxin-2, raising levels of mitochondrial ROS. To assess if xbp1 or TXNIP 
control IRE1-driven IL-1β production, we transfected BMDM with xbp1 or txnip 
specific siRNA and measured IL-1β levels. Transient knockdown of XBP1 had no 
effect on RB51-induced IL-1β production, and IL1b as well as NLRP3 transcription 
was unchanged with 4µ8C treatment (Fig. 3.1E-F and Fig. A8). Transient 
knockdown of TXNIP led to a significant decrease in IL-1β and ROS levels in 
RB51-infected BMDM. These data suggest that following RB51 infection IRE1 is 
not involved in IL-1β priming, but acts through TXNIP to induce IL-1βproduction.  
ER stress-induced mitochondrial dysfunction aids in inflammasome activation 
ER stress drives mitochondria to release mtDAMPs, which can activate the 
inflammasome [17, 21, 22]. Concomitant with the mtDAMPs release, mitochondrial 
ROS (mtROS) can increase sharply. Previous studies have shown that TXNIP 
increases overall levels of ROS in mitochondria [23]. Moreover, we observed an 
increase in ROS levels over time in RB51-infected BMDM, a phenotype dependent 
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upon IRE1 and TXNIP (Fig. 3.1H). To determine if mtROS was involved in IRE1-
induced IL-1β production, we infected BMDM derived from transgenic mice that 
express a catalase targeted to mitochondria (mCAT), thus preventing ROS 
accumulation in the mitochondrial network [24]. Both ROS and IL-1β levels 
significantly decreased in infected mCAT BMDM when compared to infected WT 
BMDM (Fig. 3.2A and B). The absence of ROS had no effect on L+A-induced IL-
1β production, consistent with previous work that demonstrated mitochondrial 
function is not essential for activation of the NLRP3 inflammasome [25]. Studies 
have reported that mtROS mediates release of mitochondrial contents into the 
cytosol. Since we observed an increase in ROS levels upon RB51 infection, we 
hypothesized that infected BMDM would release mitochondrial contents into the 
cytosol. We therefore infected BMDM with RB51 and measured cytochrome c and 
mtDNA release in comparison to tunicamycin treatment, which is known to induce 
ER stress and mitochondrial dysfunction. TM-treated and RB51-infected 
macrophages released cytochrome c and mtDNA into the cytosol, a process 
blocked by IRE1 inhibition or knockdown (Fig.3.2C and Fig. A9A and B). Since the 
presence of transfected mtDNA in the cytosol can stimulate IL-1β production [21, 
26], we investigated whether release of mitochondrial components during RB51 
infection contributed to IL-1β production by treating BMDM with cyclosporin A 
(CsA), which prevents opening of the mitochondrial permeability transition pore 
[27]. We infected BMDM with RB51 or L+A in the presence or absence of CsA, 
and measured IL-1β production by ELISA. CsA treatment significantly decreased 
IL-1β levels in RB51-infected macrophages, even though bacterial uptake was 
Figure 3.2: ER stress-induced mitochondrial dysfunction drives IL-1β
production. (A) CM-H2DCFGA was used to measure ROS levels in WT and
mitochondrial-specific catalase (mCAT) BMDM infected with RB51.
Rotenone serves as a positive control for ROS induction. (B) IL-1β levels in
RB51-infected WT and mCAT BMDM. (C) qPCR analysis of mitochondrial
DNA (mtDNA) release into cytosol during RB51 BMDM infection. (D) IL-1β
levels in RB51-infected BMDM with or without cyclosporin A (CsA, 10 μM).
Error bars in (A - D) represent mean ±SD of n≥3 independent experiments.
*** represent p-value <0.0001, n.s. = not significant. UNT, TM, and L+A
represent untreated and tunicamycin (10 µg/mL, positive control for ER
stress activation), and LPS+ATP (200 ng/mL and 1mM respectively; positive
control for inflammasome activation).
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unaffected (Fig. A10). CsA treatment did not affect IL-1β production in L+A treated 
BMDM, suggesting that our L+A treatment protocol, which results in little mtDNA 
release, induces IL-1β production independently of mitochondrial damage (Fig. 
3.2D). These data indicate that RB51 infection damages mitochondria via a IRE1-
dependent mechanism.  
NLRP3 mediates IRE1-induced mitochondrial stress in an ASC-independent 
manner  
We reasoned that NLRP3 would be the most likely sensor to respond to the 
infection-induced ER stress signal [10, 19, 28]. Upon activation, NLRP3 can 
translocate from the ER to the mitochondria [17]. NLRP3 is also reported to trigger 
mitochondrial dysfunction and IL-1β production in the presence of oxidized mtDNA 
[21, 26].  In macrophages infected with virulent B. abortus, both NLRP3 and the 
cytosolic DNA sensor AIM2 were required for IL-1β production [15]. Moreover, the 
AIM2 inflammasome was shown to regulate IL-1β production when stimulated by 
mtDNA transfected into the cell [21]. Since RB51 induced mtDNA release, we first 
assessed if AIM2 was required for RB51-induced IL-1β production by measuring 
IL-1β levels in supernatants of RB51-infected WT and Aim2-/- BMDM. We found 
that AIM2 did not contribute to IL-1β production induced by RB51 infection or by 
LPS+ATP, which depends on NLRP3 (Fig. A11).  
To determine if NLRP3 was involved in controlling the release of 
mitochondrial contents during RB51 infection, we first assessed if NLRP3 was 
recruited to mitochondria. In RB51-infected WT BMDM, NLRP3 was recruited to 
the mitochondrial fraction at 4h p.i., a time point that corresponds with cytochrome 
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c and mtDNA release (Fig. 3.3A and B). NLRP3 recruitment to the mitochondria 
was abolished in mCAT and TXNIP KD BMDM. NLRP3-deficient macrophages did 
not release mtDNA nor cytochrome c into the cytosol upon RB51 infection or 
treatment with the ER stress inducer tunicamycin (Fig. 3.3C and Fig. A12A). In 
addition, NLRP3 deficiency abolished RB51-induced IL-1β production and 
caspase-1 cleavage, but did not affect overall caspase-1 levels (Fig. 3.3D and Fig. 
A12B). Since NLRP3 appeared to be a key component of RB51-induced 
inflammasome activation, we investigated whether ASC or caspase-1, other key 
components of the canonical inflammasome, were also crucial to inducing 
mitochondrial damage. Asc-/- and YVAD-CHO (caspase-1 inhibitor)-treated BMDM 
were not required for mtDNA and cytochrome c release into the cytosol upon 
infection (Fig. 3.3C and Fig. A12C). However, ASC and caspase-1 were necessary 
for IL-1β production during RB51 infection (Fig. 3.3D). The inability to produce IL-
1β in YVAD-CHO-treated macrophages was not due to a decrease in bacterial 
uptake (Fig. A13). Together, these results show that during RB51-induced 
inflammasome activation, NLRP3 has a critical role upstream of the mitochondria, 
independent of ASC and caspase-1, in mediating release of mitochondrial 
contents.  
NLRP3 drives mitochondrial dysfunction through caspase-2  
During ER stress, we considered that NLRP3 might facilitate mitochondrial 
dysfunction through the cysteine protease caspase-2. Caspase-2 can cause 
mitochondrial dysfunction leading to cytochrome c release [29]. Moreover, 
caspase-2 is activated by ER stress or RB51 infection [30-32], and regulates 
Figure 3.3: NLRP3 is required for RB51-induced release of mitochondrial
contents. Immunoblot of NLRP3 at the mitochondrial fraction of (A) WT and
mCAT BMDM and (B) non-target (NT) and TXNIP KD BMDM. (C) Quantitative
PCR of mtDNA in cytosolic extracts from RB51-infected WT and nlrp3-/-, asc-/-,
and Z-YVAD-CHO (caspase-1 inhibitor, 2 µM) treated BMDM. (D) IL-1β levels in
RB51-infected WT and nlrp3-/-, asc-/-, and Z-YVAD-CHO (caspase-1 inhibitor, 2
µM) inhibited BMDM. Error bars represent mean ± SD of n≥3 independent
experiments. *, **, and *** represent p-values of <0.05, <0.001, and <0.0001
respectively. n.s. = not significant. UNT, TM, and LPS+ATP represent untreated,
tunicamycin (positive control for ER stress induction, 10 µg/mL), and LPS+ATP
(positive control for inflammasome activation, 200 ng/mL and 1mM) respectively.
Immunoblots in (A) and (B) are representative of n≥3 independent experiments
that were performed and imaged in parallel with identical parameters using a
LiCor Odyssey imaging system.
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caspase-1 activation [33, 34]. We reasoned that, under conditions of ER stress, 
NLRP3 might be inducing activation of caspase-2 leading to release of mtDNA and 
cytochrome c into the cytosol.  We probed lysates of control, 4µ8C-treated, as well 
as IRE1KD infected macrophages, for the full-length or cleaved active form of 
caspase-2 (Fig. 3.4A and Fig. A14A). IRE1 was required for caspase-2 cleavage 
during RB51 infection, but not for caspase-2 cleavage triggered by the positive 
control genotoxic agent, etoposide (ET), [29]. These data suggest that unlike ET, 
RB51-induced caspase-2 activation is dependent upon IRE1.  
To determine whether NLRP3 acted upstream or downstream of caspase-
2, C57BL/6 and Nlrp3-/- BMDM were infected with RB51, and lysates probed for 
cleaved caspase-2 (Fig. 3.4B). Caspase-2 cleavage was nearly absent in infected 
nlrp3-/- macrophages.  In contrast, caspase-2 cleavage appeared independent of 
ASC, as well as caspase-1, essential components for activation of the canonical 
inflammasome (Fig. A14B). In addition, caspase-2 is recruited to mitochondria in 
an IRE1 and NLRP3-dependent matter (Fig. 3.4C and D). We next assessed 
mitochondrial dysfunction in caspase-2 deficient BMDM and found that infected 
casp2-/- BMDM released significantly less mtDNA and cytochrome c into the 
cytosol (Fig. 3.4E and Fig. A14C). Moreover, caspase-2 deficiency abolished IL-
1β production and caspase-1 activation without affecting bacterial uptake (Fig. 
3.4F, Fig. A14D and E). Although these caspase-2 deficient BMDM were infected 
to similar levels as WT, it is possible that these BMDM were deficient in 
transcription of IL1b. We performed quantitative RT-PCR analysis to measure IL1b 
transcript levels in WT and casp2-/- BMDM. In the absence of caspase-2, infected 
Figure 3.4: NLRP3 and caspase-2 are required for ER stress-induced
inflammasome activation. Immunoblot analysis of caspase-2 in (A) with or
without 4µ8c (IRE1 inhibitor, 50 µM) and (B) RB51-infected WT and nlrp3-/-
BMDM. Immunoblot analysis of caspase-2 in the mitochondrial fraction (C) with
or without 4µ8c (IRE1 inhibitor, 50 µM) and (D) RB51-infected WT and nlrp3-/-
BMDM – ETǂ identifies duplicate lanes of the same sample. (E) qPCR analysis
of mtDNA in cytosolic fractions of infected WT and casp2-/- BMDM. IL-1β levels
in (F) WT and casp2-/- RB51-infected (i.p., CFU 1 x 108) BMDM and (G) WT (n =
15) and casp2-/- mice (n = 15). Data in (G) were pooled from 2 independent
experiments. (H) qPCR analysis of IL-1β transcript levels in WT and casp2-/-
RB51-infected BMDM. Error bars represent mean ± SD of n≥3 independent
experiments. *, **, and *** represent p-values of <0.05, <0.001, and <0.0001
respectively. n.s. = not significant. UNT, ET, TM, and L+A represent untreated,
etoposide (positive control for caspase-2 activation and Bid truncation, 25 µM),
tunicamycin (positive control for ER stress induction, 10 µg/mL), and LPS+ATP
(positive control for inflammasome activation, 200 ng/mL and 1mM
respectively). Immunoblots in (A-D) are representative of n≥3 independent
experiments that were performed and imaged in parallel with identical
parameters using a LiCor Odyssey imaging system. Full length caspase-2 and
TOM20 (mitochondrial specific outer membrane protein) serve as loading
controls.
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BMDM still produced similar levels of IL1b to WT BMDM (Fig. 3.4G) suggesting 
that the defect in IL-1β production is not in priming but in activating the 
inflammasome. Similar to our in vitro data, casp2-/- mice exhibited low serum IL-1β 
levels and higher bacterial burden in the spleen (Fig. 3.4H). These data suggest 
that NLRP3 can mediate RB51-induced mitochondrial damage and inflammasome 
activation by a caspase-2-dependent mechanism.  
NLRP3 and caspase-2 induce mitochondrial damage via Bid truncation 
We next aimed to elucidate the mechanism by which NLRP3 and caspase-
2 could regulate mitochondrial dysfunction. NLRP3 and caspase-2 could lead to 
activation of Bid, which damages mitochondria by licensing pore formation of Bax 
and Bak, pro-apoptotic factors of the Bcl-2 family [35]. Caspase-2 can truncate Bid 
(tBid), leading to activation [35]. To determine if Bid was involved in RB51-induced 
mitochondrial damage, we infected 4µ8C-treated or IRE1KD macrophages with 
RB51 and probed for the presence of tBid. Etoposide served as a positive control 
condition for Bid truncation. Total Bid levels remained constant under all 
conditions, but Bid truncation was diminished in 4µ8C-treated and IRE1KD 
macrophages (Fig. 3.5A and Fig. A15A), implicating Bid in RB51-induced 
mitochondrial dysfunction. ET induces mitochondrial dysfunction but does not 
induce ER stress [36, 37]. Therefore, it was not surprising to see that IRE1 
inhibition had no effect on Bid truncation in ET-treated BMDM. To determine the 
role of NLRP3 and caspase-2 in this process, C57BL/6, Nlrp3-/-, and Casp2-/- 
BMDM were infected with RB51 to assay Bid truncation, which was markedly 
decreased in the absence of NLRP3 and caspase-2 (Fig. 3.5B and Fig. A15B). 
Figure 3.5: NLRP3 controls mitochondrial dysfunction by a Bid dependent
mechanism. Bid truncation in RB51-infected (A) with or without 4µ8c (IRE1
inhibitor, 50 µM) and (B) WT and nlrp3-/- BMDM – ETǂ identifies duplicate lanes
of the same sample. (C) Quantitation of mtDNA in cytosolic extracts from RB51-
infected WT and bid-/- BMDM. (D) ELISA of IL-1β levels in supernatants from
RB51-infected WT and bid-/- BMDM. (E) Immunoblot analysis of caspase-1 in WT
and bid-/- BMDM infected with RB51. (f) Serum IL-1β levels in WT (n = 29) and
bid-/- (n = 30) mice RB51-infected (i.p. CFU 1 x 108) mice. The data in (F) were
pooled from 2 independent experiments. Error bars represent mean ± SD of n≥3
independent experiments. * and *** represent p-values of <0.05 and <0.0001
respectively. n.s. = not significant. UNT, ET, TM, and L+A represent untreated,
etoposide (positive control for Bid truncation, 25 µM), tunicamycin (positive
control for ER stress induction, 10 µg/mL), and LPS+ATP (positive control for
inflammasome activation, 200 ng/mL and 1mM) respectively. Immunoblots in (A),
(B), and (E) are representative of n≥3 independent experiments that were
performed and imaged in parallel with identical parameters using a LiCor
Odyssey imaging system. Full length (FL) caspase-1 and Bid serve as loading
controls.
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Infected Bid-/- BMDM released significantly less mtDNA into the cytosol than 
wildtype controls, confirming that Bid is required for mitochondrial damage, even 
though Bid-deficiency did not affect bacterial uptake (Fig. 3.5C and Fig. A15C). 
Bid-/- BMDM infected with RB51 also exhibited diminished secretion of IL-1β and 
caspase-1 cleavage (Fig. 3.5D and E). Consistent with our in vitro results, RB51-
infected Bid-/- mice showed a significant decrease in serum IL-1β, as well as an 
increase in bacterial burden in the spleen, compared to wildtype controls (Fig. 3.5F 
and Fig. A16). Thus, during RB51 infection, NLRP3 and caspase-2 trigger 
mitochondrial damage through Bid, leading to inflammasome activation. 
NLRP3 and caspase-2 are required for inflammasome activation in response to 
UPR-inducing chemicals 
Our data thus far identified the IRE1-NLRP3-caspase2-Bid axis as a 
mechanism for relaying infection-induced ER stress signals to the mitochondria, 
leading to inflammasome activation. We considered the possibility that this 
pathway might be important for infection-induced inflammasome activation, but not 
in the general ER stress response. We therefore tested whether IRE1, NLRP3, 
caspase-2 and Bid were required for inflammasome activation in response to 
thapsigargin (TG), tunicamycin (TM), and brefeldin A (BFA), three chemical 
inducers of ER stress that act by distinct mechanisms. The sesquiterpene lactone, 
thapsigargin, is a selective inhibitor of Ca2+ uptake from the cytosol by ER Ca2+ 
ATPases [38], which results in net loss of ER luminal Ca2+ and ER stress. 
Tunicamycin, a nucleoside antibiotic, inhibits N-glycosylation of proteins in the 
Golgi apparatus resulting in ER stress [39]. Brefeldin A, a fungal lactone antibiotic, 
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induces disassembly as well as collapse of the Golgi into the ER leading to a 
backup of Golgi protein in the ER and ER stress [40].  Treatment of WT BMDM 
with TG, TM, or BFA resulted in weak IL-1β production, but robust caspase-1 
cleavage, suggesting that minimal priming was occurring during TG, TM, and BFA 
treatment in contrast to L+A treatment (Fig. 3.6A and B). Priming to stimulate IL1b 
transcription, and inflammasome activation are the two signals required for robust 
IL-1β secretion [41]. We assessed proIL-1β production by immunoblot and found 
that unlike LPS, TM and BFA induced weak proIL-1β production whereas TG did 
not trigger any detectable proIL-1β production (Fig. A17A). These data suggest 
that ER stress can serve as the second signal for inducing inflammasome 
activation, but is a weak inducer of the first signal (priming) that regulates 
transcription of IL1b. When we assessed inflammasome activation, we found that 
similar to our infection model, caspase-1 cleavage was abrogated in 4µ8C-treated 
BMDM in the presence of TG and TM (Fig.3.6B). Although BFA did trigger IRE1 
activation (Fig. A17B), IRE1 was not required for BFA-induced inflammasome 
activation, as previously reported by Tschopp and colleagues [10], perhaps due to 
the more extensive perturbations induced by BFA, compared to TG or TM. In TM 
and TG-treated BMDM deficient in NLRP3, caspase-2, and Bid, caspase-1 
cleavage was virtually absent (Fig. 3.6C-E).  Although caspase-2 and Bid were 
critical for sterile ER stress-induced inflammasome activation, neither was required 
for inflammasome activation by L+A (Fig. 3.6D and E). Taken together, our data 
support the IRE1-NLRP3-caspase2-Bid axis as a key mechanism by which general 
ER stress drives mitochondrial damage and inflammasome activation. 
Figure 3.6: NLRP3 and caspase-2 are required for caspase-1 activation
during ER stress. (A) ELISA analysis of IL-1β levels in supernatants from
BMDM treated with L+A (LPS+ATP, 200 ng/mL and 1mM respectively; positive
control for inflammasome activation), or the ER stressors BFA (brefeldin A, 20
µM), TM (tunicamycin, 10 µg/mL), and TG (thapsigargin, 10 µM). Error bars
represent mean ± SD of n≥3 independent experiments. ** and *** represent p-
values of <0.001 and <0.0001 respectively. n.s. = not significant. Immunoblot
analysis of caspase-1 in (B) BMDM in the absence or presence of 4µ8c (IRE1
inhibitor, 50 µM), (C) WT and nlrp3-/- BMDM – L+Aǂ identifies duplicate lanes of
the same sample, (D) WT and casp2-/- BMDM, and (E) WT and bid-/- BMDM.
Immunoblots in (B-E) are representative of n≥3 independent experiments that
were performed and imaged in parallel with identical parameters using a LiCor
Odyssey imaging system. Full length (FL) caspase-1 serves as a loading
control.
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Conclusions 
 ER stress is increasingly implicated in human disease, including infection, 
Alzheimer’s Disease and diabetes [42]. More recent studies, have demonstrated a 
connection between ER stress and the inflammasome, although the mechanisms 
that control signaling have not been fully elucidated [10, 19, 28]. Our results reveal 
that activation of the IRE1 ER stress sensor leads to NLRP3-mediated crosstalk 
between ER and mitochondria, resulting in release of mitochondrial contents 
through activation of the caspase-2/Bid axis (Fig. 3.7A). Notably, the requirement 
of NLRP3 in ER stress-induced mitochondrial damage was independent of ASC 
and caspase-1, suggesting that this is not a function of the canonical 
inflammasome. Our data place NLRP3 upstream of caspase-2 in the ER-
mitochondrial signaling pathway, and provide a mechanism by which NLRP3 can 
facilitate mitochondrial damage to activate the inflammasome. Whether NLRP3 or 
additional inflammasome regulators act as downstream sensors of mitochondrial 
damage in ER stress conditions remains to be determined, although AIM2 was not 
required.  
The role of mitochondria in activating inflammasomes has been somewhat 
controversial. Previously, K+ efflux was proposed as a common mechanism by 
which diverse stresses that increase membrane permeability, e.g., bacterial toxins 
or LPS+ATP, activate the NLRP3 inflammasome without requiring mitochondrial 
damage [25, 43].  However, other studies have reported that mitochondrial 
damage was critical for inflammasome activation by LPS+ATP or by cytosolic DNA 
[26, 44, 45].  In the conditions we used, NLRP3-dependent inflammasome 
Figure 3.7: Working model of IRE1-induced inflammasome activation.
Upon IRE1 activation, TXNIP translocates to the mitochondria and increases
ROS levels. The increase in ROS levels, recruits NLRP3 and caspase-2 to
the mitochondria and triggers Bid truncation. The processing of Bid is
required for mtDNA and cytochrome c release, indicative of mitochondrial
damage. Release of mtDAMPs aids in activation of the NLRP3-ASC-
caspase-1 inflammasome. Blockade of ROS, caspase-2, Bid, or mtDAMPs
release will lead to decreased NLRP3-dependent inflammasome activation
and IL-1β production. (B) Oligomerization of NLRP3 oligomerization
(cytosolic vs. mitochondrial anchored) depends upon the magnitude of ER
stress. Regardless of location, NLRP3 aids in IL-1β processing.
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activation by LPS+ATP was essentially independent of IRE1, caspase-2, Bid, or 
mitochondrial content release.  However, ER stress-induced inflammasome 
activation both provoked and required mitochondrial damage.  To reconcile our 
results with previously published reports, we propose that NLRP3-dependent 
oligomerization, necessary for inflammasome activation, may exhibit distinct 
signaling requirements depending on the types or magnitude of stress (Fig. 3.7B).  
For example, a stress that initiates strong K+ efflux, such as pore formation by 
bacterial toxins or pannexin-1, might not require mitochondrial damage and would 
not be blocked by cyclosporin A.  Stress that triggers weaker K+ efflux might be 
more dependent on mitochondrial danger signals.  Notably, protocol-specific 
conditions may be critical in defining the reliance of inflammasome activation on 
K+ efflux vs. mitochondrial damage [21, 26, 46].  In fact, we found that differing 
times and concentrations of LPS+ATP treatments resulted in substantially different 
levels of mtDNA release (Fig. A18), perhaps providing an explanation for why 
conflicting results have been reported.  Therefore, the molecular context of cellular 
stress will likely be critical in defining the key principles that govern inflammasome 
activation.     
Microbial infection imposes complex stress conditions upon infected cells 
that are not fully defined for most microbes, but may include K+ efflux, nutrient 
deprivation, cytoskeletal perturbations and ROS.   Microbes or microbial ligands 
activate IRE1 through TLR signaling [9], and in vivo data clearly show that XBP1, 
a component of the IRE1 signaling pathway, and NLRP3 can mediate resistance 
to microbial infection [9, 16]. These observations are consistent with the idea that 
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activation of ER stress machinery influences the outcome of infection by tuning 
inflammatory responses.  Importantly, a recent study demonstrated that IRE1 was 
required for optimal secretion of pro-inflammatory cytokines, including IL-1β, in a 
mouse model of inflammatory arthritis [47]. Cellular stress in the form of ER 
perturbation and mitochondrial dysfunction may provide critical contextual danger 
signals that together with microbial ligands provoke robust immunity. Because ER 
stress and mitochondrial dysfunction are also associated with Type 2 diabetes, 
obesity, Crohn’s disease and cancer [48, 49], it will be of interest to determine 
whether the NLRP3-caspase-2 regulatory axis is more broadly involved in sterile 
inflammatory diseases.  
NLRP3 has emerged as a critical regulator of the inflammasome in 
response to ER stress and IRE1 activation. How IRE1 leads to NLRP3-dependent 
stimulation of caspase-2 is still unclear.  NLRP3 binds to the signaling adaptor, 
TXNIP, whose levels are controlled by activated IRE1 [19, 28, 50], suggesting that 
interaction as a possible interface that may lead to recruitment and cleavage of 
caspase-2.  Alternatively, NLRP3 may interact with an accessory protein similar to 
ASC that recruits caspase-2 through its CARD domain. IRE1 itself was reported to 
modulate caspase-2 total protein levels by controlling degradation of regulatory 
microRNAs in BFA, TG, or TM-treated murine embryonic fibroblasts [32]. However, 
a recent report indicated that overall caspase-2 levels did not change in response 
to ER stress induced in human leukemia- and lymphoma-derived cell lines [51], 
which is in agreement with our data in macrophages showing that caspase-2 
cleavage is the key event induced by ER stressors. Our results emphasize the 
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requirement for caspase-2 and mitochondrial damage in triggering caspase-1 
activation specifically in conditions for ER stress since mitochondrial damage is 
not absolutely required for other triggers of the NLRP3 inflammasome [25].  
Determining specific mechanisms by which ER stress tunes the inflammatory 
response will lay the groundwork for better design of therapeutic approaches for 
diseases of inflammation and immunity. 
Materials and Methods 
Mice 
Humane animal care at the University of Michigan is provided by the Unit for Lab 
Animal Medicine, which is accredited by the American Association for 
Accreditation of Laboratory Animal Care and the Department of Health and Human 
Services. This study was carried out in strict accordance with the 
recommendations in the Guide for the Care and Use of Laboratory Animals of the 
National Institutes of Health. The protocol was approved by the Committee on the 
Care and Use of Animals (UCUCA) of the University of Michigan. 
Bid WT (n = 29), bid-/-[52] (n = 30), DMSO treated  (n = 15),4µ8c treated (n = 15), 
casp2 WT (n = 15) and casp2-/- (n = 15) C57BL/6 mice (8 -12 weeks) were injected 
intraperitoneally (i.p.) with Brucella abortus RB51 vaccine strain (1 x 108 CFU) in 
200 µl of phosphate-buffered saline (PBS). Mice were matched by sex and age. 
Mice were treated with DMSO (5% in PBS) and 4µ8c (25mg/kg) daily in 200 µl of 
PBS. Blood was collected by saphenous vein on day -1, 1, and 3 days post 
infection (p.i.). Serum was extracted from blood by centrifugation for 3 min at 
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10,000 rpm and used for assessing IL-1β production by ELISA.  At day 3 p.i., 
spleens were removed from euthanized mice, homogenized in 1 ml 0.2% NP-40, 
and serial dilutions plated onto Brucella agar plates to enumerate CFU.  
Cell culture and infection 
BMDM were isolated from WT, casp2-/-, asc-/-, nlrp3-/-, bid-/- and aim2-/- mice. 
Casp2-/- with corresponding WT were purchased from Jackson Laboratories (stock 
#007899) [53]. Nlrp3-/- [54] and asc-/- [55] were maintained by the Nuñez 
laboratory. Bid-/- [52] and corresponding WT mice were maintained by the Yin 
laboratory. Aim2-/- [56] and corresponding WT mice were maintained by the 
Fitzgerald laboratory.  
Isolated BMDM were differentiated in DMEM (GIBCO) supplemented with 20% 
heat-inactivated FBS (Invitrogen), 1% L-glutamine (2 mM), 1% sodium pyruvate (1 
mM), 0.1% β-mercaptoethanol (55 µM), and 30% L-929 conditioned medium. 
BMDM were cultured in non-TC treated plates at 37°C in 5% CO2, fed fresh media 
on day 3, and harvested on day 6. Four million RAW264.7 macrophages or BMDM 
were seeded in 6 well plates 18 hr prior to infection. The LPS+ATP samples were 
pretreated with LPS (200 ng/mL) overnight. The following day, where indicated, 
cells were pretreated with cyclosporin A (10 μM), TUDCA (300 μM), 4μ8c (50 μM), 
and Y-VAD-CHO (2 μM) for 1 hr prior to infection. Untreated and pretreated cells 
were infected with RB51 (MOI 200) for 30 min, after which the inoculum was 
removed and cells were washed with PBS. Medium containing 50 µg/ml of 
gentamicin was added to kill extracellular bacteria. To synchronize infection, cells 
were spun at 1200 rpm for 3 min after adding inoculum. Cells were treated with 
88 
 
etoposide (25 μM), thapsigargin (10 μM), tunicamycin (10 μg/mL), brefeldin A (20 
μM), or ATP (1mM) for 4 hr. At the indicated times, cells were lysed in buffer 
containing 1% NP-40 on ice for 15 min and spun at 16,000 x g for 15 min to pellet 
the insoluble fraction. Soluble fractions were used for immunoblot assays. The 
insoluble fraction was resuspended in mitochondrial suspension buffer (10mM 
TrisHCl pH 6.7, 0.15 mM MgCl2, 0.25 sucrose, 1 mM PMSF, 1 mM DTT) and 
centrifuged at 11,000 x g for 15 minutes at 4ºC to pellet the isolated mitochondria. 
Purity of isolated mitochondria was assessed by immunoblotting for calreticulin - 
ER marker, TOM20- mitochondrial marker, Lamin B1 - nuclear marker, and Actin 
- cytosolic marker (Fig. A19).  
Bacterial strains and reagents 
 Brucella abortus strain RB51 was obtained from Dr. G. Schurig (Virginia 
Polytechnic Institute and State University). Reagents were obtained from the 
following vendors: cyclosporin A (Sigma-Aldrich), thapsigargin (Fisher), 
tunicamycin (Sigma-Aldrich), etoposide (Sigma-Aldrich), brefeldin A (Sigma-
Aldrich), TUDCA (Calbiochem), 4μ8c (Axon), ATP (Sigma-Aldrich), and Y-VAD-
CHO (Santa Cruz). Antibodies were obtained from the following vendors: anti-
PERK (cat#: 3192S, Cell Signaling), anti-p-PERK (cat#: sc-32577, Santa Cruz), 
anti-ATF6 (cat#: sc-22799, Santa Cruz), anti-IRE1 (cat#: 3294S, Cell Signaling), 
anti-NLRP3 (cat.# MAB7578, Fisher), anti-cytochrome c (cat#:4272S, Cell 
Signaling), anti-caspase-2 (cat#: 3027-100, BioVision), anti-caspase-1 (cat#: sc-
514, Santa Cruz), anti-Bid (cat#: 2003S, Cell Signaling), anti-Calreticulin (cat.# 
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2891, Cell Signaling), anti-TOM20 (cat.# sc-11415, Santa Cruz), anti-Actin (cat#: 
MS1295P1, Thermo Scientific), and anti-Lamin-b1 (cat#: sc-20682, Santa Cruz). 
Lentivirus production and knockdown of IRE1 
HEK293T cells were grown in DMEM with 10% fetal bovine serum (Invitrogen). 
Lentivirus particles were produced by transfecting the cells with the TRC shRNA 
encoding plasmid (pLKO.1) along with the packaging plasmids (pVSV-G, pGAG-
PAL) obtained from the University of Michigan Vector Core. The medium was 
changed after 24 hr, and virus particles collected at 48 hr.  Virus-containing 
medium was concentrated 10-fold by centrifugation (24000 rpm) for 2 hr at 4°C. 
Concentrated virus was used to transduce RAW264.7 cells seeded in 60-mm 
dishes. The medium was changed 24 hr post transduction and cells were left to 
grow for an additional 24 hr. Transduced cells were selected with puromycin (4 
μg/mL). The mouse specific IRE1 shRNA plasmid with antisense sequence of (5’-
TTTCTCTATCAATTCACGAGC-3’) was purchased from Open Biosystems. The 
non-targeted control shRNA plasmid was purchased from Sigma-Aldrich.  
siRNA knockdown of TXNIP and xbp1 
Immortalized BMDM were transfected with specific Dharmacon siGENOME TXNIP 
siRNA (cat# M-040441-01-0005), xbp1 (cat.# M-040825-00-0005) or non-target 
siRNA (cat.# D-001206-13-20) using DharmaFECT 4 transfection reagent 
according to the manufacturer’s protocol. Knockdown efficiency was assessed via 
immunoblot using anti-TXNIP (cat.# NBP1-54578, Novus Biologicals) and anti-
xbp1 (cat.# ab37152, Abcam) antibodies.  
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ROS measurements  
BMDM were plated in a 96 well plate with black slides and clear bottom. At 
designated time points, BMDM were washed with PBS and then incubated with 
CM-H2DCFDA (Invitrogen) at a final concentration of 2.5 µM in Ringer buffer (155 
mM NaCl, 5 mM KCl, 1 mM MgCl2 6H2O, 2 mM NaH2PO4 H2O, 10 mM HEPES, 10 
mM glucose). Cell were incubated for 30 min at 37ºC, washed three times with 
cold PBS, and incubated for an additional 15 min at 37ºC in warm media for 
recovery. After recovery, cells were washed one more time with PBS. Florescence 
was measured at excitation/emission 485nm/525nm.  
Immunoblot Assay 
Cytosolic extracts collected at indicated time points (2, 4, and 8 hr pi) were 
separated by SDS-PAGE, transferred to nitrocellulose membranes (Millipore), 
blocked with 5% nonfat dry milk in TBS-0.1% Tween20 (TBS-T), and incubated 
overnight at 4°C with primary antibodies specified above. Membranes were 
washed with TBS-T and incubated with secondary IRDye 680LT Goat anti-rabbit 
or IRDye 680LT Goat anti-mouse (1:20,000) at room temperature for 1 hr. Bands 
were visualized using the Li-Cor Odyssey Infrared Imaging System. Immunoblots 
shown in the figures are representative of n≥3 independent experiments. All 
immunoblots shown within an individual panel were analyzed in parallel with 
identical parameters using the Li-Cor System. 
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Cytokine Analysis 
Culture supernatants were collected at indicated time points from macrophages 
infected as described. IL-1β levels were determined by sandwich enzyme-linked 
immunosorbent assay (ELISA) according to the manufacturer’s instructions 
(BioLegend). A minimum of 3 technical replicates per experiment and 3 
experimental replicates were analyzed for each condition. 
Xbp1 splicing assay 
Total RNA (2 µg) extracted from samples was prepared using the RNeasy Mini Kit 
(Qiagen) and used for cDNA synthesis. Primers encompassing the spliced 
sequences in xbp1 mRNA (forward 5’-GAACCAGGAGTTAAGAACACG-3’ and 
reverse 5’-AGGCAACAGTGTCAGAGTCC-3’) were used for PCR amplification 
with GoTaq polymerase (Invitrogen). The thermal cycling profile consisted of 30 
cycles at 94°C for 1 min, 60°C for 1 min, and 72°C for 1 min.  PCR products were 
incubated with PstI (Invitrogen) at 37°C overnight. PstI digested products were 
separated by electrophoresis through a 2.5% agarose gel.  
Mitochondrial DNA (mtDNA) release assay 
DNA was isolated from 200 µL of the cytosolic fraction using a DNeasy Blood & 
Tissue Kit (Qiagen). Quantitative PCR was employed to measure mtDNA using 
Brilliant II SYBR Green with Low ROX (Agilent Technologies) on a Stratagene 
MX300 QPCR System. The copy number of mtDNA encoding cytochrome c 
oxidase I was normalized to nuclear DNA encoding 18S ribosomal RNA. The 
following primers were used:  cytochrome c oxidase I (forward 5’-
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GCCCCAGATATAGCATTCCC-3’ and reverse 5’-GTTCATCCTGTTCCTGCTCC-
3’) and 18S rRNA (forward 5’-TAGAGGGACAAGTGGCGTTC-3’ and reverse 5’-
CGCTGAGCCAGTCAGTGT-3’).  
Lactate dehydrogenase (LDH) Release Assay 
Macrophages were seeded in 96-well plates and infected with RB51 as stated 
above. Supernatants were analyzed for the presence of LDH enzyme using the 
CytoTox-ONE™ Homogeneous Membrane Integrity Assay (Promega) as directed 
by the manufacturer’s instructions. Percentage of LDH release was calculated as 
100 X [(Experimental LDH Release - Culture Medium Background)/(Maximum 
LDH Release – Culture Medium Background)]. 
Statistical Analysis  
All p values were generated between identified samples using unpaired two-tailed 
Student’s t-tests and represent analysis of ≥3 replicates per condition. Asterisks 
denote the following p values: *p<0.05, **p<0.001 and ***p<0.0001. 
Author Contributions:  
DNB, YH, and MXDO designed the experiments. DNB, BA, and MXDO performed 
the experiments. BA, KF, GN, YH, XC, and XMY contributed critical reagents, 
materials, and discussion. DNB and MXDO analyzed the data and wrote the paper.   
Author Information:  
The authors have declared that no competing interests exist.   
 
93 
 
Acknowledgments  
We acknowledge members of the O’Riordan lab for many helpful discussions. We 
thank Drs. D. Monack and V. Carruthers, for critical review of the manuscript. We 
are grateful to Dr. V. Rathinam, Dr. Yuan He, and Dr. D. Ron for providing critical 
reagents and experimental guidance.  We thank the staff of the UM Unit for 
Laboratory Animal Medicine that provided assistance with saphenous vein blood 
collection. The University of Michigan Vector Core provided the TRC shRNA 
plasmids for IRE1 knockdown. We acknowledge financial support from the 
University of Michigan Rackham Graduate School (YH and DNB) and Michigan 
Genetics Training Fellowship (DNB, GM007544). This research was supported by 
funding from the NIH to MXDO (AI101777), KAF (AI083713), GN (AI063331, 
AR059688), XMY (AA021751), and funds from the University of Michigan Medical 
School Unit for Laboratory Animal Medicine and Endowment for Basic Science 
(YH). The funders had no role in study design, data collection and analysis, 
decision to publish, or preparation of the manuscript. 
 
 
 
 
 
 
94 
 
References 
1. Zhang, Q., et al., DAMPs and autophagy: cellular adaptation to injury and 
unscheduled cell death. Autophagy, 2013. 9(4): p. 451-8. 
 
2. Kono, H. and K.L. Rock, How dying cells alert the immune system to 
danger. Nat Rev Immunol, 2008. 8(4): p. 279-89. 
 
3. Brown, M.K. and N. Naidoo, The endoplasmic reticulum stress response in 
aging and age-related diseases. Front Physiol, 2012. 3: p. 263. 
 
4. Davis, B.K., H. Wen, and J.P. Ting, The inflammasome NLRs in immunity, 
inflammation, and associated diseases. Annu Rev Immunol, 2011. 29: p. 707-35. 
 
5. Hao, L.Y., X. Liu, and L. Franchi, Inflammasomes in inflammatory bowel 
disease pathogenesis. Curr Opin Gastroenterol, 2013. 29(4): p. 363-9. 
 
6. Tan, M.S., et al., The NLRP3 Inflammasome in Alzheimer's Disease. Mol 
Neurobiol, 2013. 
 
7. Subramanian, N., et al., The adaptor MAVS promotes NLRP3 mitochondrial 
localization and inflammasome activation. Cell, 2013. 153(2): p. 348-61. 
 
8. Hetz, C., The unfolded protein response: controlling cell fate decisions 
under ER stress and beyond. Nat Rev Mol Cell Biol, 2012. 13(2): p. 89-102. 
 
9. Martinon, F., et al., TLR activation of the transcription factor XBP1 regulates 
innate immune responses in macrophages. Nature immunology, 2010. 11(5): p. 
411-8. 
 
10. Menu, P., et al., ER stress activates the NLRP3 inflammasome via an UPR-
independent pathway. Cell Death Dis, 2012. 3: p. e261. 
 
11. Pillich, H., et al., Activation of the unfolded protein response by Listeria 
monocytogenes. Cell Microbiol, 2012. 14(6): p. 949-64. 
 
12. Seimon, T.A., et al., Induction of ER stress in macrophages of tuberculosis 
granulomas. PloS one, 2010. 5(9): p. e12772. 
 
13. Bischof, L.J., et al., Activation of the unfolded protein response is required 
for defenses against bacterial pore-forming toxin in vivo. PLoS Pathog, 2008. 
4(10): p. e1000176. 
 
14. Li, X. and Y. He, Caspase-2-dependent dendritic cell death, maturation, and 
priming of T cells in response to Brucella abortus infection. PLoS One, 2012. 7(8): 
p. e43512. 
95 
 
15. Gomes, M.T., et al., Critical role of ASC inflammasomes and bacterial type 
IV secretion system in caspase-1 activation and host innate resistance to Brucella 
abortus infection. J Immunol, 2013. 190(7): p. 3629-38. 
 
16. von Moltke, J., et al., Recognition of bacteria by inflammasomes. Annu Rev 
Immunol, 2013. 31: p. 73-106.  
 
17. Zhou, R., et al., A role for mitochondria in NLRP3 inflammasome activation. 
Nature, 2011. 469(7329): p. 221-5. 
 
18. Zeng, Y. and A.D. Elbein, UDP-N-acetylglucosamine:dolichyl-phosphate N-
acetylglucosamine-1-phosphate transferase is amplified in tunicamycin-resistant 
soybean cells. Eur J Biochem, 1995. 233(2): p. 458-66.  
 
19. Lerner, A.G., et al., IRE1alpha induces thioredoxin-interacting protein to 
activate the NLRP3 inflammasome and promote programmed cell death under 
irremediable ER stress. Cell Metab, 2012. 16(2): p. 250-64.  
 
20. Cross, B.C., et al., The molecular basis for selective inhibition of 
unconventional mRNA splicing by an IRE1-binding small molecule. Proc Natl Acad 
Sci U S A, 2012. 109(15): p. E869-78. 
 
21. Nakahira, K., et al., Autophagy proteins regulate innate immune responses 
by inhibiting the release of mitochondrial DNA mediated by the NALP3 
inflammasome. Nat Immunol, 2011. 12(3): p. 222-30. 
 
22. Iyer, S.S., et al., Mitochondrial cardiolipin is required for nlrp3 
inflammasome activation. Immunity, 2013. 39(2): p. 311-23. 
 
23. Saxena, G., J. Chen, and A. Shalev, Intracellular shuttling and mitochondrial 
function of thioredoxin-interacting protein. J Biol Chem, 2010. 285(6): p. 3997-
4005. 
24. Lee, H.Y., et al., Targeted expression of catalase to mitochondria prevents 
age-associated reductions in mitochondrial function and insulin resistance. Cell 
Metab, 2010. 12(6): p. 668-74. 
 
25. Munoz-Planillo, R., et al., K(+) efflux is the common trigger of NLRP3 
inflammasome activation by bacterial toxins and particulate matter. Immunity, 
2013. 38(6): p. 1142-53. 
 
26. Shimada, K., et al., Oxidized mitochondrial DNA activates the NLRP3 
inflammasome during apoptosis. Immunity, 2012. 36(3): p. 401-14. 
 
27. Handschumacher, R.E., et al., Cyclophilin: a specific cytosolic binding 
protein for cyclosporin A. Science, 1984. 226(4674): p. 544-7. 
 
96 
 
28. Oslowski, C.M., et al., Thioredoxin-interacting protein mediates ER stress-
induced beta cell death through initiation of the inflammasome. Cell Metab, 2012. 
16(2): p. 265-73. 
 
29. Robertson, J.D., et al., Caspase-2 acts upstream of mitochondria to 
promote cytochrome c release during etoposide-induced apoptosis. J Biol Chem, 
2002. 277(33): p. 29803-9. 
 
30. Chen, F. and Y. He, Caspase-2 mediated apoptotic and necrotic murine 
macrophage cell death induced by rough Brucella abortus. PLoS One, 2009. 4(8): 
p. e6830. 
 
31. Upton, J.P., et al., Caspase-2 cleavage of BID is a critical apoptotic signal 
downstream of endoplasmic reticulum stress. Mol Cell Biol, 2008. 28(12): p. 3943-
51. 
 
32. Upton, J.P., et al., IRE1alpha cleaves select microRNAs during ER stress 
to derepress translation of proapoptotic Caspase-2. Science, 2012. 338(6108): p. 
818-22. 
 
33. Jesenberger, V., et al., Salmonella-induced caspase-2 activation in 
macrophages: a novel mechanism in pathogen-mediated apoptosis. J Exp Med, 
2000. 192(7): p. 1035-46. 
 
34. Bronner, D.N., M.X. O'Riordan, and Y. He, Caspase-2 mediates a Brucella 
abortus RB51-induced hybrid cell death having features of apoptosis and 
pyroptosis. Front Cell Infect Microbiol, 2013. 3: p. 83. 
 
35. Korsmeyer, S.J., et al., Pro-apoptotic cascade activates BID, which 
oligomerizes BAK or BAX into pores that result in the release of cytochrome c. Cell 
Death Differ, 2000. 7(12): p. 1166-73. 
 
36. Hitomi, J., et al., Involvement of caspase-4 in endoplasmic reticulum stress-
induced apoptosis and Abeta-induced cell death. J Cell Biol, 2004. 165(3): p. 347-
56. 
37. Wang, X.Z., et al., Identification of novel stress-induced genes downstream 
of chop. EMBO J, 1998. 17(13): p. 3619-30. 
 
38. Thastrup, O., et al., Thapsigargin, a tumor promoter, discharges 
intracellular Ca2+ stores by specific inhibition of the endoplasmic reticulum Ca2(+)-
ATPase. Proc Natl Acad Sci U S A, 1990. 87(7): p. 2466-70. 
 
39. Olden, K., R.M. Pratt, and K.M. Yamada, Role of carbohydrates in protein 
secretion and turnover: effects of tunicamycin on the major cell surface 
glycoprotein of chick embryo fibroblasts. Cell, 1978. 13(3): p. 461-73. 
 
97 
 
40. Pahl, H.L. and P.A. Baeuerle, A novel signal transduction pathway from the 
endoplasmic reticulum to the nucleus is mediated by transcription factor NF-kappa 
B. EMBO J, 1995. 14(11): p. 2580-8. 
 
41. Schroder, K. and J. Tschopp, The inflammasomes. Cell, 2010. 140(6): p. 
821-32. 
42. Wang, S. and R.J. Kaufman, The impact of the unfolded protein response 
on human disease. J Cell Biol, 2012. 197(7): p. 857-67. 
 
43. Allam, R., et al., Mitochondrial apoptosis is dispensable for NLRP3 
inflammasome activation but non-apoptotic caspase-8 is required for 
inflammasome priming. EMBO Rep, 2014. 
 
44. Franchi, L., et al., Cytosolic Double-Stranded RNA Activates the NLRP3 
Inflammasome via MAVS-Induced Membrane Permeabilization and K+ Efflux. J 
Immunol, 2014. 
 
45. Heid, M.E., et al., Mitochondrial Reactive Oxygen Species Induces NLRP3-
Dependent Lysosomal Damage and Inflammasome Activation. J Immunol, 2013. 
 
46. Horng, T., Calcium signaling and mitochondrial destabilization in the 
triggering of the NLRP3 inflammasome. Trends Immunol, 2014. 35(6): p. 253-61. 
 
47. Qiu, Q., et al., Toll-like receptor-mediated IRE1alpha activation as a 
therapeutic target for inflammatory arthritis. EMBO J, 2013. 32(18): p. 2477-90. 
 
48. Garg, A.D., et al., ER stress-induced inflammation: does it aid or impede 
disease progression? Trends Mol Med, 2012. 18(10): p. 589-98. 
 
49. Escames, G., et al., Mitochondrial DNA and inflammatory diseases. Hum 
Genet, 2012. 131(2): p. 161-73. 
 
50. Zhou, R., et al., Thioredoxin-interacting protein links oxidative stress to 
inflammasome activation. Nat Immunol, 2010. 11(2): p. 136-40. 
 
51. Sandow, J.J., et al., ER stress does not cause upregulation and activation 
of caspase-2 to initiate apoptosis. Cell Death Differ, 2014. 21(3): p. 475-80. 
 
52. Yin, X.M., et al., Bid-deficient mice are resistant to Fas-induced 
hepatocellular apoptosis. Nature, 1999. 400(6747): p. 886-91. 
 
53. Bergeron, L., et al., Defects in regulation of apoptosis in caspase-2-deficient 
mice. Genes Dev, 1998. 12(9): p. 1304-14. 
 
54. Kanneganti, T.D., et al., Bacterial RNA and small antiviral compounds 
activate caspase-1 through cryopyrin/Nalp3. Nature, 2006. 440(7081): p. 233-6. 
98 
 
 
55. Ozoren, N., et al., Distinct roles of TLR2 and the adaptor ASC in IL-1beta/IL-
18 secretion in response to Listeria monocytogenes. J Immunol, 2006. 176(7): p. 
4337-42. 
 
56. Rathinam, V.A., et al., The AIM2 inflammasome is essential for host 
defense against cytosolic bacteria and DNA viruses. Nat Immunol, 2010. 11(5): p. 
395-402. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
99 
 
 
 
 
Chapter 4 
PERK suppresses inflammasome activity via Parkin-dependent mitophagy 
 
Abstract 
Controlling the extent of inflammatory signaling is critical for effective immune 
responses to infection, while minimizing host damage. Previously, we found that 
infection-induced activation of the endoplasmic reticulum stress sensor, IRE1, led 
to mitochondrial damage and triggered the NLRP3-dependent inflammasome. The 
mechanisms that downregulate IRE1-induced inflammasome activation are poorly 
defined. Here we show that PERK, a second ER stress sensor, dampens IRE1-
induced IL-1β production in vitro and in vivo. Microbial activation of the PERK 
signaling pathway induced transcription of parkin, which encodes an E3 ubiquitin 
ligase that regulates mitophagy. Parkin recruitment to mitochondria promoted 
fragmentation of the mitochondrial network, as well as a decrease in IL-1β 
production. Inhibition of PERK or mitochondrial fission increased IL-1β production 
induced by infection-associated ER stress. These data provide evidence that 
PERK-dependent mitophagy can play a suppressive role in regulating 
inflammatory responses to infection.  
Introduction 
Endoplasmic reticulum (ER) and mitochondrial stress programs can 
contribute to progression of degenerative and inflammatory diseases [1-4]. 
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Previous work has implicated ER stress in triggering inflammatory responses 
during infection. Recognition of microbes by Toll-like receptors (TLR) stimulates 
the ER stress sensor, IRE1, increasing transcription of proinflammatory cytokines 
IL-6 and TNFα [5]. Previously, we discovered that IRE1 induces IL-1β production 
by increasing mitochondrial reactive oxygen species (mtROS). The rapid increase 
in mtROS recruited NLRP3 and caspase-2 to the mitochondria, facilitating damage 
and release of mitochondrial contents into the cytosol. The newly released 
mitochondrial danger associated molecular patterns (mtDAMPs) activated the 
inflammasome, a multiprotein complex that processes the proinflammatory 
cytokine, IL-1β [6, 7]. Although IRE1 acts as the initiator of this ER stress-induced 
process, mechanisms for modulating this potential inflammatory signaling pathway 
are poorly defined. Previous studies identified autophagy as a key mechanism that 
could suppress inflammation by eliminating signaling molecules that trigger 
inflammasome activation [7-9]. Damaged mitochondria are removed by 
mitophagy, a mitochondrial-specific form of autophagy. Our previous studies 
indicated that infection-induced ER stress causes mitochondrial damage, leading 
us to hypothesize that mitophagy might be employed to downregulate that 
inflammatory process.   
Here we show that the ER stress sensor PERK can modulate IRE1-induced 
inflammasome activity.  We provide evidence that inflammasome activity is 
suppressed by PERK-dependent mitophagy.  These data reveal a novel regulatory 
role for PERK during infection and inflammation, and demonstrate that ER stress 
sensors can fine-tune inflammatory output during infection. 
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Results 
Microbial viability affects IL-1β processing but not priming 
Previously, we showed that IRE1 is critical in triggering inflammasome 
activation and IL-1β production during infection by the live attenuated cattle 
vaccine Brucella abortus strain RB51. Treatment of bone marrow derived 
macrophages (BMDM) with heat-killed (HK) RB51 resulted in significantly less IL-
1β secretion compared to live RB51 (Fig. 4.1A). To determine whether HK RB51 
stimulated less cytokine transcription (priming) or less cytokine translation, we 
measured proIL-1β protein production by immunoblot and found that HK-infected 
and Live-infected BMDM expressed similar levels of proIL-1β (Fig. 4.1B). Taken 
together, these observations suggested that the absence of IL-1β might be due to 
decreased activity of the inflammasome, leading to less processing of proIL-1β. 
We first tested whether HK could activate IRE1 similarly to live RB51 by measuring 
splicing of xbp1 transcript, a direct downstream target of IRE1, in Live and HK-
infected BMDM. Xbp1 splicing was comparable in both Live and HK-infected 
BMDM at 8h post infection (pi) (Fig. A20A). These data indicate that the effect of 
HK treatment on inflammasome activation was likely occurring downstream of 
IRE1.   
With no difference in IRE1 activation, we investigated whether activation of 
the other two ER stress sensors, ATF6 and PERK, differed between Live and HK-
infected BMDM. ATF6 cleavage, indicative of activation, occurred in both Live and 
HK-infected BMDM (Fig. A20B). Notably, HK RB51 triggered PERK activation, as 
assessed by phosphorylation (Fig. 4.2A). To determine if PERK could serve as a 
Fig 4.1: IL-1β processing, not priming, depends upon microbial viability.
(A) IL-1β ELISA analysis of supernatants from Live and HK RB51-infected
BMDM. Error bars represent mean ± SD of n≥3 independent experiments. ***
represent p-value <0.0001, n.s. = not significant. (B) Immunoblot of proIL-1β
in Live and HK RB51-infected (MOI 20) BMDMs. Immunoblots in (B) are
representative of n≥3 independent experiments performed and imaged using
a LiCor Odyssey imaging system.
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Fig. 4.2: PERK suppresses IRE1-induced inflammasome activation. (A)
PERK phosphorylation in Live and HK RB51-infected (MOI 20) BMDM. PERK
and TM served as the loading and positive controls respectively. (B) IL-1β ELISA
analysis of supernatants from Live and HK RB51-infected BMDM in the
presence of GSK-PERK (GSK2606414 specific PERK inhibitor, 5 μM) and ATF4
siRNA. Error bars represent mean ± SD of n≥3 independent experiments. ***
represent p-value <0.0001, n.s. = not significant. (C) Caspase-1 cleavage in Live
and HK RB51-infected (MOI 20) BMDMs in absence or presence of
GSK2606414. (D) Serum IL-1β levels in mice treated with 5% DMSO (control, n
= 12) or GSK2606414 (n = 12) and infected with HK RB51 (i.p., CFU equivalent
1 x 108). Data in (D) were pooled from 2 independent experiments. Immunoblots
in (A) and (C) are representative of n≥3 independent experiments performed and
imaged using a LiCor Odyssey imaging system.
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switch to negatively regulate IL-1β production, we utilized two approaches: a 
PERK-specific inhibitor (GSK-PERK2606414 or GSK-PERK, locks PERK in an 
inactive state) and siRNA knockdown of ATF4, a transcription factor that is 
preferentially translated when the PERK signaling pathway is activated. L+A 
(LPS+ATP) served as a positive control for inflammasome activation and triggers 
IL-1β production independently of ER stress. GSK-PERK treatment as well as 
ATF4 knockdown (KD) had no effect on L+A and Live-induced IL-1β production 
and caspase-1 cleavage (activation) in BMDM, conditions where there is no PERK 
activation (Fig. 4.2B and C). In contrast, GSK-PERK and ATF4 KD led to a 
significant increase in IL-1β production and sustained caspase-1 cleavage in HK-
infected BMDM. Consistent with our in vitro findings, GSK-PERK-treated mice 
injected with HK RB51 showed a significant increase in serum IL-1β compared to 
control-treated mice (Fig. 4.2D). These data point to PERK as a possible 
suppressor of IRE1-induced inflammasome activation during infection. 
PERK minimizes induction of IRE1-mediated mitochondrial dysfunction 
 In Live-infected BMDM, mitochondrial damage was essential for 
inflammasome activation, a process initiated by IRE1. With IRE1 activation, but a 
lack of IL-1β production in HK-infected BMDM, we hypothesized that PERK might 
interfere with IRE1-induced mitochondrial damage. The mitochondrial membrane 
potential (Δѱm) is a key indicator of mitochondrial health or damage [10]. Normal 
and healthy mitochondria have a high Δѱm, whereas damaged mitochondria have 
low Δѱm. We measured Δѱm with JC-1, a mitochondrial probe whose red 
fluorescence decreases as Δѱm dissipates [11]. Treatment with carbonyl cyanide 
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m-chlorophenyl hydrazine (CCCP, a mitochondrial proton gradient uncoupler) or 
Live RB51 caused the Δѱm to drop significantly (Fig. 4.3A). In HK-infected BMDM, 
the Δѱm decreased at 2h pi but increased after 4h pi – when we observe robust 
activation of PERK. Only in the presence of the PERK inhibition did Δѱm levels 
decrease persistently in HK-infected BMDM. With a sharp decrease in Δѱm, 
mitochondria release mtDNA into the cytosol and mtROS accumulates. We 
measured mtDNA cytosolic release by qPCR and found that Live-infected BMDM 
contained substantial amounts of cytosolic mtDNA (Fig. 4.3B). HK-infected BMDM 
initially released mtDNA into the cytosol, however after 4h p.i., this release was 
abrogated, a phenotype seen with caspase-1 activation. Release of mtDNA 
increased throughout HK infection in GSK-PERK-treated or ATF KD BMDM (Fig. 
A21A). ROS levels were relatively low in HK-infected and TM-treated BMDM, 
consistent with low levels of mtDNA release, but increased upon GSK-PERK 
treatment or ATF4 KD (Fig. 4.3C and Fig. A21B). In contrast, ROS levels were 
high in Live-infected BMDM and were unaffected by PERK inhibition or ATF4 KD. 
Together, these results indicate that PERK signaling can interfere with IRE1-driven 
mitochondrial damage.  
PERK induces mitochondrial fragmentation via mitophagy 
 Autophagy can suppress proinflammatory responses by eliminating 
damaged organelles and pathogens [7, 8]. Previous studies reported that PERK 
coordinates the transcription of the gene encoding Beclin-1, an initiator of 
autophagy [12]. Moreover, PERK signaling may enhance conversion of LC3, a 
process required for autophagosome formation [13]. These observations led us to 
Fig. 4.3: PERK inhibits IRE1-driven mitochondrial damage. (A) Fluorescence
images and quantification of JC-1 staining of BMDMs treated with CCCP
(mitochondrial uncoupler, 20 μM) or infected with Live and HK RB51 (MOI 20).
The ratio of JC-1 red/green fluorescence represents the mitochondrial membrane
potential (Δѱm). (B) qPCR analysis of mitochondrial DNA (mtDNA) release into
cytosol during Live and HK RB51 BMDM infection in the absence or presence of
GSK2606414. (C) CM-H2DCFDA was used to measure ROS levels with or
without GSK2606414 in Live and HK-RB51 infected BMDM. Tunicamycin (TM)
serves as a positive control for ROS induction.
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hypothesize that PERK could be preventing release of mtDAMPs by autophagic 
removal of damaged mitochondria, thus inhibiting inflammasome activation. We 
therefore tested if autophagy was involved in controlling IL-1β production in HK-
infected macrophages, using Beclin-1+/- and Lc3b-/- BMDM. Neither Beclin-1 
haploinsufficiency nor LC3 deficiency had any effect on L+A-induced and Live-
induced IL-1β production in BMDM (Fig. 4.4A). Deficiency in LC3, but not Beclin-
1, led to an increase in IL-1β levels in HK-infected BMDM. These data establish 
that beclin-1-dependent autophagy is not involved in PERK-mediated suppression 
of IL-1β, but implicate LC3 in this process.  
We reasoned that removal of damaged mitochondria via mitophagy could 
be the mechanism of PERK-mediated suppression of the inflammasome. When 
mitochondria are damaged, PINK1 accumulates on the outer mitochondrial 
membrane serving as a tag. PINK accumulation recruits the E3 ubiquitin ligase, 
Parkin, to the mitochondrial network resulting in ubiquitination of mitochondrial 
proteins. This triggers fragmentation and eventual capture of damaged 
mitochondria by LC3+ autophagosomes. A recent study reported that PERK can 
control mitophagy by regulating transcription of parkin in an ATF4-dependent 
manner. Since we observed an increase in IL-1β production in LC3 deficient HK-
infected BMDM, we next assessed the induction of mitophagy by probing PINK1 
accumulation, as well as LC3 and PARKIN recruitment to the mitochondrial fraction 
by immunoblot. CCCP is a potent inducer of mitophagy and served as a positive 
control. PINK1 accumulated in the mitochondrial fraction of Live-infected, HK-
infected, and CCCP-treated BMDM, consistent with mitochondrial damage (Fig. 
Fig. 4.4: PERK drives removal of damaged mitochondria via mitophagy. (A)
IL-1β levels in Beclin-1+/- and LC3B-/- BMDM infected with Live and HK-RB51. (B)
Immunoblot of mitophagy markers PINK1, LC3-II, and PARKIN in the
mitochondrial fraction of CCCP and Live/HK-infected BMDM. TOM20 serves as
loading control and mitochondrial marker. (C) 3-D reconstruction and
quantification of the mitochondrial network labeled with TOM20 (mitochondrial
marker, outer membrane protein) with or without GSK2606414 in CCCP and
Live/HK-infected BMDM. Colors represent the size of the fragments within the
network. Error bars in (A and C) represent mean ±SD of n≥3 independent
experiments. ** and *** represent p-values <0.001 and <0.0001 respectively. n.s. =
not significant. UNT, CCCP, and L+A represent untreated and Carbonyl cyanide
m-chlorophenyl hydrazine (20 µM, positive control for mitophagy induction), and
LPS+ATP (200 ng/mL and 1mM respectively; positive control for inflammasome
activation).
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4.4B). Notably, PINK1 accumulation began to decrease after 4h p.i. only in HK-
infected cells, suggesting the possibility that damaged mitochondria were being 
removed and degraded in HK-infected BMDM. Additionally, we observed PARKIN 
and LC3 mitochondrial recruitment only in HK-infected BMDM, but not Live-
infected BMDM. This result further indicated that mitochondrial damage occurs 
early in HK infection.  
Next, we assessed if PERK contributed to mitophagy induction in HK-
infected BMDM. GSK-PERK treatment or ATF4 KD abolished PARKIN and LC3 
recruitment in HK-infected BMDM (Fig. 4.4B and Fig. A21C). PINK1 levels 
increased in HK-infected BMDM treated with GSK-PERK, suggesting that removal 
of damaged mitochondria was inhibited, consistent with increased inflammasome 
activity and IL-1β levels.  
Upon induction of mitophagy, the mitochondrial network fragments, allowing 
for damaged mitochondria to be separated from the network to maintain network 
integrity [14]. To quantify mitochondrial fragmentation, we measured length and 
volume of the mitochondrial network by confocal immunofluorescence imaging and 
deconvolution of the TOM20 outer mitochondrial membrane protein. We observed 
that CCCP treatment and HK infection led to a significantly fragmented phenotype, 
as well as a decrease in isosurface volume and length of the mitochondrial network 
(Fig. 4.4C). Although Live infection induced damage, the mitochondrial network 
did not fragment further, consistent with our observations that mitophagy does not 
occur in Live-infected BMDM. GSK-PERK treatment or ATF4 KD in HK-infected 
BMDM yielded a largely intact mitochondrial network, with increased volume and 
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length (Fig. 4.4C and Fig. A21D). These data demonstrate that PERK signaling 
can serve as a trigger for mitophagy.  
PERK prevents inflammasome activation by Parkin-dependent mitophagy 
 Fragmentation of the mitochondrial network allows for capture of damaged 
mitochondria and is dependent upon Parkin, which is transcriptionally regulated by 
the PERK signaling pathway during ER stress conditions [15]. We observed that 
HK induced Parkin transcription, whereas in Live-infected BMDM, Parkin transcript 
levels were similar to UNT levels (Fig. 4.5A). Additionally, HK-induced Parkin 
transcription was abrogated by PERK inhibition. These observations led us to 
hypothesize that Parkin-driven mitophagy was the critical mechanism for PERK-
mediated inflammasome suppression in HK-infected BMDM. To test this idea, we 
infected Parkin-/- BMDM or BMDM treated with Mdivi-1, a mitochondrial fission 
inhibitor [16], with HK and measured IL-1β levels. Parkin deficiency resulted in a 
significant increase in IL-1β production in HK-infected but not Live-infected or 
LPS+ATP treated BMDM (Fig, 4.5B). Similar to Parkin deficiency, Mdivi-1 
treatment also increased IL-1β levels, suggesting that fragmentation was essential 
in inflammasome suppression in HK-treated BMDM. HK did not induce 
mitochondrial fragmentation in Parkin-/- nor Mdivi-1 treated BMDM (Fig. 4.5C). 
Although IL-1β levels increased in HK-infected LC3b-/- BMDM, the mitochondrial 
network was still able to fragment, further supporting that the autophagic capture 
of damaged mitochondria aids in removing mtDAMPs, suppressing inflammasome 
activation and IL-1β production (Fig. A22). These results demonstrate that PERK 
suppresses inflammasome activation through PARKIN-mediated mitophagy. 
Fig. 4.5: PERK-induced mitophagy is mediated by Parkin. (A) qPCR analysis
of PARKIN transcription during Live and HK RB51 BMDM infection in the absence
or presence of GSK2606414. Tunicamycin (TM) serves as a positive control for
PARKIN induction. (B) IL-1β ELISA analysis of supernatants from Live and HK
RB51-infected WT, Parkin-/-, and Mdivi-1 (mitochondrial fission inhibitor, 20 μM)
treated BMDM. Error bars represent mean ± SD of n≥3 independent experiments.
*** represents p-values of <0.0001, n.s. = not significant. L+A (LPS+ATP, 200
ng/mL and 1mM respectively) serves as a positive control for inflammasome
activation. (C) 3-D reconstruction and quantification of the mitochondrial network
labeled with TOM20 (mitochondrial marker, outer membrane protein) of CCCP
treated and Live/HK-infected WT, Parkin-/-, and Mdivi-1 BMDM. Colors represent
the size of the fragments within the network. Error bars in (A - C) represent mean
±SD of n≥3 independent experiments. ** and *** represent p-values <0.001 and
<0.0001 respectively. n.s. = not significant.
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Parkin-dependent mitophagy decreases RSV-induced inflammation in vivo 
Mitophagy may be important in controlling NLRP3 inflammasome activation 
and promoting cell survival during infection.  However, HK RB51 is not a useful 
model to study the role of mitophagy in infection since there are no live bacteria. 
Viral pathogens can hijack this mitophagic process to aid in viral replication by 
dampening innate immune responses and preventing apoptosis [17-21]. 
Respiratory syncytial virus (RSV), a single stranded RNA (- ssRNA) virus, is a 
major cause of lower respiratory tract infections and pneumonia symptoms in 
infants and children [22]. Previous studies have found that RSV proteins colocalize 
with the mitochondrial network [23, 24]. As seen with Live RB51, IRE1 and ROS 
are important for RSV-induced NLRP3-mediated IL-1β production [25]. Moreover, 
LC3b deficiency led to elevated IL-1β levels and lung pathology in RSV-infected 
mice. These observations suggest that mitophagy can aid in decreasing 
inflammasome activation and IL-1β production during RSV infection.  
IRE1 is activated during RSV infection, however it is not known if PERK 
activation occurs as seen in HK-infected BMDM. We were able to observe 
phosphorylation of PERK and induction of CHOP, a downstream transcriptional 
target of PERK, in RSV-infected BMDM (Fig. 4.6A). To assess if mitophagy was 
occurring, we probed for PINK1 and Parkin/LC3 as markers of mitophagy in RSV-
infected BMDM. PINK1 tagging of damaged mitochondria occurred early, and 
removal of mitochondria began at 4 hr post infection in RSV-infected BMDM (Fig. 
4.6B). Similar to HK-infected BMDM, GSK-PERK treatment led to increased PINK1 
accumulation but decreased Parkin and LC3 recruitment in RSV-infected BMDM. 
Fig. 4.6: PERK and Parkin mediate RSV-induced mitophagy. (A) PERK
phosphorylation and CHOP induction in RSV-infected (MOI 1) BMDM. PERK and
TM served as the loading and positive controls respectively. (B) Immunoblot of
mitophagy markers PINK1, LC3-II, and PARKIN in the mitochondrial fraction of
CCCP and RSV-infected BMDM. TOM20 serves as loading control and
mitochondrial marker. C) 3-D reconstruction and quantification of the mitochondrial
network labeled with TOM20 (mitochondrial marker, outer membrane protein) of
CCCP treated and RSV-infected WT, Parkin-/-, and GSK2606414-treated BMDM.
Colors represent the size of the fragments within the network. Error bars in (A - C)
represent mean ±SD of n≥3 independent experiments. ** and *** represent p-
values <0.001 and <0.0001 respectively. n.s. = not significant.
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We observed mitochondrial fragmentation in RSV-infected BMDM – a phenotype 
that decreased in GSK-PERK treated and Parkin deficient BMDM (Fig. 4.6C). 
Moreover, parkin transcription decreased in GSK-PERK-treated RSV-infected 
BMDM (Fig. A23). Parkin deficiency exerted a greater effect on fragmentation than 
PERK inhibition, suggesting that another inducer of Parkin is involved in RSV-
induced mitophagy. Since we observed mitophagy in RSV-infected BMDM, we 
assessed whether mitophagy was important in regulating inflammasome 
activation. GSK-PERK treatment and Parkin deficiency led to increased IL-1β 
production and caspase-1 activation in vitro (Fig. 4.7A and Fig. A24A-B). 
Consistent with our in vitro data, we observed increased IL-1β production in RSV-
infected mice treated with GSK-PERK (Fig. 4.7B). Taken together, our data identify 
Parkin-dependent mitophagy as a mechanism by which PERK can suppress ER-
stress induced inflammasome activation.  
Conclusions 
Recent studies have demonstrated that ER stress can trigger mitochondrial 
dysfunction, as well as aid in autophagy, a process known for preventing 
accumulation of damaged mitochondria [26]. There is significant evidence showing 
that mitochondrial dysfunction promotes the progression of neurodegenerative and 
inflammatory diseases [4, 27, 28]. Although PERK can mediate an antioxidant 
response [12, 29] and promote autophagy, it has not been linked to inflammasome 
regulation. In this study, we provide evidence for a model where PERK acts as a 
suppressor of inflammasome activation by driving Parkin-dependent mitophagy 
during infection (Fig. 4.8). When mitochondrial damage occurs, whether microbial 
Fig. 4.7: Mitophagy decreases RSV-induced inflammation in vitro and in vivo.
(A) IL-1β ELISA analysis of supernatants from RSV-infected GSK2606414-treated
(specific PERK inhibitor, 5 μM) and Parkin-/- BMDM. Error bars represent mean ±
SD of n≥3 independent experiments. *** represent p-value <0.0001, n.s. = not
significant. (B) Lung IL-1β levels in mice treated with 5% DMSO (control n = 5) or
GSK2606414 (n = 5) and infected with RSV.
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Fig. 4.8: PERK drives Parkin-mediated mitophagy to suppress the
inflammasome. IRE1-induced mitochondrial damage and ROS production
triggers PINK1 accumulation on the outer membrane of mitochondria. Upon
PERK activation, ATF4 translocates to the nucleus and initiates Parkin
transcription. Parkin is recruited to damaged mitochondria tagged with PINK1
and ubiquitinates outer membrane proteins. Ubiquitination of mitochondrial
proteins triggers fragmentation and allows for capture of dysfunctional
mitochondria by the isolation membrane. Once captured, the autophagosome
fuses with the lysosome and degrades the damaged mitochondria.
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or chemically induced, PINK1 accumulates on the surface serving as a tag for 
dysfunctional mitochondria. If PERK is activated, it signals ATF4-dependent parkin 
transcription. Parkin is recruited to mitochondria, initiating fragmentation of the 
network and allowing the capture of damaged mitochondria by autophagosomes. 
The removal of damaged mitochondria would lead to the observed decrease in 
mtDAMPs, preventing oligomerization or activation of the inflammasome on the 
mitochondrial surface and the lack of sustained caspase-1 activation. We 
previously demonstrated that NLRP3 and caspase-2 are recruited to the 
mitochondrial network; therefore, it is possible that NLRP3 and caspase-2 are 
being captured and degraded along with damaged mitochondria. Caspase-2 
activation, similar to caspase-1, is not sustained during HK infection – an 
observation that supports the hypothesis of caspase-2 being captured with 
damaged mitochondria. Furthermore, we demonstrated that this PERK-dependent 
inflammasome suppression pathway can be triggered by microbial infections in 
vitro and in vivo. Our studies have uncovered a novel role for PERK in controlling 
inflammasome activity during infection.  
Previous studies that implicated mitophagy in inflammasome activation 
demonstrated that LC3b deficiency increased IL-1β production and caspase-1 
activation upon treatment with LPS+ATP and viral infections [7]. Since LC3b is 
involved in both autophagy and mitophagy, it remained unclear which pathway was 
involved. Our study now demonstrates that Parkin-mediated mitophagy, distinct 
from the beclin-1 autophagy pathway, can suppress IL-1β production during 
microbial infection. Similar to LC3b deficiency, we showed that Parkin deficiency 
118 
 
increased IL-1β production and caspase-1 activation. Inhibition of PERK or ATF4 
KD led to higher levels of cytosolic mtDNA, suggesting that damaged mitochondria 
were accumulating within the cell. More damaged mitochondria in the cell and 
increased mtDNA levels are consistent with the sustained inflammasome 
activation we observed.  
Activation of PERK by chemical inducers (e.g. tunicamycin) leads to 
increased transcription of parkin by ATF4 [15]. ATF4 induction is controlled by the 
alpha subunit of eukaryotic initiation factor 2 (eIF2α). Upon phosphorylation, eIF2α 
reduces general translation while facilitating the preferential translation of ATF4. 
This eIF2α-ATF4 pathway can be triggered by several kinases in different stress 
conditions: PERK (ER stress), GCN2 (amino acid deficiency), HRI (heavy metals), 
and protein kinase R (PKR, viral infection). We found that in HK-infected BMDM, 
ATF4-induced parkin transcription was solely dependent upon PERK whereas in 
RSV-infected BMDM it was only partially dependent upon PERK. Reports show 
that RSV can activate PKR leading to phosphorylation of eIF2α [30, 31]. In 
addition, PKR can induce autophagy leading to viral degradation during infection 
[32]. These observations suggest the possibility that in BMDM, RSV activates both 
PERK and PKR thus triggering ATF4-dependent parkin transcription. If this is 
occurring, both PERK and PKR may act to control inflammasome output with the 
right contextual signals.  
Additional evidence has surfaced showing that microbial infections can 
selectively activate UPR sensors [5]. Most studies indicate that IRE1 is important 
for triggering inflammatory responses, whereas PERK is critical for suppressing 
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global translation and triggering cell death. Our work shows that selective 
activation of ER stress sensors may allow the ER to control the amplitude and 
kinetics of the  inflammatory response. The observation that PERK was able to 
prevent IRE1-induced mitochondrial damage in microbial infections highlights the 
fact that ER stress signaling is not limited to initiating inflammation. Viral pathogens 
are known for exploiting autophagy to increase their chances for replication and 
preventing cell death [19-21, 33].  RSV might selectively activate PERK as a 
means of suppressing inflammation and increasing pathogenesis. Understanding 
the mechanism of selective activation of ER stress sensors may lead to better 
therapeutic strategies for diseases that involve ER stress and mitochondrial 
dysfunction.   
Materials and Methods 
Mice 
Humane animal care at the University of Michigan is provided by the Unit for Lab 
Animal Medicine, which is accredited by the American Association for 
Accreditation of Laboratory Animal Care and the Department of Health and Human 
Services. This study was carried out in strict accordance with the 
recommendations in the Guide for the Care and Use of Laboratory Animals of the 
National Institutes of Health. The protocol was approved by the Committee on the 
Care and Use of Animals (UCUCA) of the University of Michigan. 
C57BL/6 5% DMSO treated (n = 12), GSK-PERK2606414 treated (n = 12) mice (8 
-12 weeks) were injected intraperitoneally (i.p.) with Brucella abortus RB51 vaccine 
strain (1 x 108 CFU) in 200 µl of phosphate-buffered saline (PBS). Mice were 
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matched by sex and age. Mice were treated with DMSO (5% in PBS) and GSK-
PERK2606414 (50mg/kg) daily in 200 µl of PBS. Blood was collected by 
saphenous vein on day -1, 1, and 3 days post infection (p.i.). Serum was extracted 
from blood by centrifugation for 3 min at 10,000 rpm and used for assessing IL-1β 
production by ELISA. At day 3 p.i., spleens were removed from euthanized mice, 
homogenized in 1 ml 0.2% NP-40, and serial dilutions plated onto Brucella agar 
plates to enumerate CFU. 
Cell culture and infection 
BMDMs were isolated from WT C57BL/6 mice and were differentiated in DMEM 
(GIBCO) supplemented with 20% heat-inactivated FBS (Invitrogen), 1% L-
glutamine (2 mM), 1% sodium pyruvate (1 mM), 0.1% β-mercaptoethanol (55 µM), 
30% L-929 conditioned medium, and J2 recombinant retrovirus. BMDMs were 
cultured in non-TC treated plates at 37°C in 5% CO2, fed fresh media on day 3, 
and harvested on day 6. Four million BMDMs were seeded in 6 well plates 18 hr 
prior to infection. The LPS+ATP samples were pretreated with LPS (200 ng/mL) 
overnight. The following day, where indicated, cells were pretreated with GSK-
PERK2606414 (PERK specific inhibitor, 5 μM) and Mdivi-1 (mitochondrial fission, 
20 μM) for 1 hr prior to infection. Untreated and pretreated cells were infected with 
Live and HK RB51 (MOI 20) for 30 min or after which the inoculum was removed 
and cells were washed with PBS. Medium containing 50 µg/ml of gentamicin was 
added to kill extracellular bacteria. To synchronize infection, cells were spun at 
1200 rpm for 3 min after adding inoculum. Cells were treated with tunicamycin (10 
μg/mL), Carbonyl cyanide m-chlorophenyl hydrazine (CCCP, 20 μM), or ATP 
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(1mM) for 4 hr. At the indicated times, cells were lysed in RIPA buffer on ice for 15 
min and spun at 16,000 x g for 15 min to pellet debris. For mitochondrial fractions, 
cells were lysed in buffer 1% NP-40 on ice for 15 min and spun at 16,000 x g for 
15 min to pellet the insoluble fraction. The insoluble fraction was resuspend in 
mitochondrial suspension buffer (10mM TrisHCl pH 6.7, 0.15 mM MgCl2, 0.25 
sucrose, 1 mM PMSF, 1 mM DTT) and centrifuged at 11,000 x g for 15 minutes at 
4ºC to pellet the isolated mitochondria.  
Respiratory Syncytial Virus (RSV) 
All RSV experiments utilized antigenic subgroup A, Line 19 strain RSV obtained 
from Dr. N. Lukacs (University of Michigan). The strain was originally isolated from 
a sick infant in the University of Michigan Health System. Cells were pretreated 
with GSK-PERK2606414 (PERK specific inhibitor, 5 μM) for 1 hr prior to RSV 
infection (MOI 1). At the indicated times, cells were lysed in RIPA buffer on ice for 
15 min and spun at 16,000 x g for 15 min to pellet debris. For mitochondrial 
fractions, cells were lysed in buffer 1% NP-40 on ice for 15 min and spun at 16,000 
x g for 15 min to pellet the insoluble fraction. The insoluble fraction was resuspend 
in mitochondrial suspension buffer (10mM TrisHCl pH 6.7, 0.15 mM MgCl2, 0.25 
sucrose, 1 mM PMSF, 1 mM DTT) and centrifuged at 11,000 x g for 15 minutes at 
4ºC to pellet the isolated mitochondria. 
Bacterial strains and reagents 
Brucella abortus strain RB51 was obtained from Dr. G. Schurig (Virginia 
Polytechnic Institute and State University). Aliquots of RB51 were subjected to 
heat killing by incubating at 70ºC in a water bath for 60 min. HK bacterial 
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preparations were confirmed to be nonviable by plating aliquots on Brucella agar 
plates and confirming lack of growth following 4 days of incubation. Reagents were 
obtained from the following vendors: tunicamycin (Sigma-Aldrich), CCCP (Sigma-
Aldrich), Mdivi-1 (Fisher), and ATP (Sigma-Aldrich). Antibodies were obtained from 
the following vendors: anti-PERK (cat#: 3192S, Cell Signaling), anti-p-PERK (cat#: 
sc-32577, Santa Cruz), anti-ATF6 (cat#: sc-22799, Santa Cruz), anti-caspase-1 
(cat#: sc-514, Santa Cruz), PINK1 (cat#: BC100-494, Novus Biologicals), LC3B 
(cat#: NB100-2331, MBL), PARKIN (cat#: 4211, Cell Signaling), and anti-TOM20 
(cat.# sc-11415, Santa Cruz). 
siRNA knockdown of ATF4 
Immortalized BMDMs were transfected with specific Dharmacon siGENOME ATF4 
siRNA (cat# M-042737-01-0005) or non-target siRNA (cat.# D-001206-13-20) 
using DharmaFECT 4 transfection reagent according to the manufacturer’s 
protocol. Knockdown efficiency was assessed via immunoblot using anti-ATF4 
(cat.# sc-200) antibodies (Fig. A25). 
ROS measurements  
BMDMs were plated in a 96 well plate with black slides and clear bottom. At 
designated time points, BMDMs were washed with PBS and then incubated with 
CM-H2DCFDA (Invitrogen) at a final concentration of 2.5 µM in Ringer buffer (155 
mM NaCl, 5 mM KCl, 1 mM MgCl2 6H2O, 2 mM NaH2PO4 H2O, 10 mM HEPES, 
10 mM glucose). Cell were incubated for 30 min at 37ºC, washed three times with 
cold PBS, and incubated for an additional 15 min at 37ºC in warm media for 
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recovery. After recovery, cells were washed one more time with PBS. Florescence 
was measured at excitation/emission 485nm/525nm.  
Immunoblot Assay 
Whole cell and mitochondrial extracts collected at indicated time points (2, 4, and 
8 hr pi) were separated by SDS-PAGE, transferred to nitrocellulose membranes 
(Millipore), blocked with 5% nonfat dry milk in TBS-0.1% Tween20 (TBS-T), and 
incubated overnight at 4°C with primary antibodies specified above. Membranes 
were washed with TBS-T and incubated with secondary IRDye 680LT Goat anti-
rabbit or IRDye 680LT Goat anti-mouse (1:20,000) at room temperature for 1 hr. 
Bands were visualized using the Li-Cor Odyssey Infrared Imaging System. 
Immunoblots shown in the figures are representative of n≥3 independent 
experiments. All immunoblots shown within an individual panel were analyzed in 
parallel with identical parameters using the Li-Cor System. 
Cytokine Analysis 
Culture supernatants were collected at indicated time points from macrophages 
infected as described. IL-1β levels were determined by sandwich enzyme-linked 
immunosorbent assay (ELISA) according to the manufacturer’s instructions 
(BioLegend). A minimum of 3 technical replicates per experiment and 3 
experimental replicates were analyzed for each condition. 
Xbp1 splicing assay 
Total RNA (2 µg) extracted from samples was prepared using the RNeasy Mini Kit 
(Qiagen) and used for cDNA synthesis. Primers encompassing the spliced 
sequences in xbp1 mRNA (forward 5’-GAACCAGGAGTTAAGAACACG-3’ and 
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reverse 5’-AGGCAACAGTGTCAGAGTCC-3’) were used for PCR amplification 
with GoTaq polymerase (Invitrogen). The thermal cycling profile consisted of 30 
cycles at 94°C for 1 min, 60°C for 1 min, and 72°C for 1 min. PCR products were 
incubated with PstI (Invitrogen) at 37°C overnight. PstI digested products were 
separated by electrophoresis through a 2.5% agarose gel. 
Mitochondrial DNA (mtDNA) release assay 
DNA was isolated from 200 µL of the cytosolic fraction using a DNeasy Blood & 
Tissue Kit (Qiagen). Quantitative PCR was employed to measure mtDNA using 
Brilliant II SYBR Green with Low ROX (Agilent Technologies) on a Stratagene 
MX300 QPCR System. The copy number of mtDNA encoding cytochrome c 
oxidase I was normalized to nuclear DNA encoding 18S ribosomal RNA. The 
following primers were used:  cytochrome c oxidase I (forward 5’-
GCCCCAGATATAGCATTCCC-3’ and reverse 5’-GTTCATCCTGTTCCTGCTCC-
3’) and 18S rRNA (forward 5’-TAGAGGGACAAGTGGCGTTC-3’ and reverse 5’-
CGCTGAGCCAGTCAGTGT-3’). 
JC-1 staining for mitochondrial membrane potential (Δѱm) 
Four million BMDMs were seeded into a 96-well black plate. Cells were treated 
with 5 µl of JC-1 staining solution (Life Technologies) then treated with CCCP or 
infected with Live and HK RB51. Fluorescence of JC-1 in treated cells  was 
measured at various time points using the following excitation and emission 
wavelengths: 560nm/595nm (aggregates) and 485nm/535nm (monomers). 
For fluorescence microscopy, 3 x 105 cells were seeded in a 60 mm glass-bottom 
dish. Cells were treated with 100 µl of JC-1 staining then treated with the conditions 
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stated above. Healthy mitochondria were detected with fluorescence settings 
designed to detect Texas Red (excitation/emission: 590/610nm).  
Parkin qPCR 
RNA was isolated from treated BMDM using a RNeasy Midi Kit (Qiagen). cDNA 
was synthesized from the extracted RNA using the SuperScript III First-Strand 
Synthesis System (Life Technologies). Quantitative PCR was employed to 
measure PARKIN transcript levels using Brilliant II SYBR Green with Low ROX 
(Agilent Technologies) on a Stratagene MX300 QPCR System. The copy number 
of PARKIN was normalized to Actin. The following primers were used:  PARKIN 
(forward 5’-AAACCGGATGAGTGGTGAGT-3’ and reverse 5’-
AGCTACCGACGTGTCCTTGT-3’). 
Confocal microscopy and 3-D reconstruction of mitochondrial network 
BMDM were seeded onto square coverslips in 6 well plates at a density of 3×105 
per well the night before infection. The day of infection, host cells were treated with 
CCCP (positive control of fragmentation) or infected with Live and HK RB51 as 
stated above. Coverslips were rinsed using DPBS (+ calcium and magnesium) and 
fixed in 4% paraformaldehyde. After fixation, coverslips were rinsed three times in 
TBS+0.1% Triton-X 100 and stained with the mitochondrial marker TOM20 (1:350) 
for 45 minutes, stained with secondary Cy3 (1:100) for 45 minutes, and 
counterstained with DAPI (1:1000) for 15 minutes.  Coverslips were mounted onto 
slides using Prolong Gold Anti-Fade (Invitrogen). Cells were imaged at the 
Microscopy and Image Analysis (MIL) core at the University of Michigan Medical 
School using an Nikon A-1 inverted fluorescence microscope. Images were 
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collected using the Nikon Elements software with diode lasers 405 (DAPI) and 561 
(Cy3) with a Z-stack step size of 0.200 µm. Z-stacks of images were combined 
using Metamorph to obtained a single image. The stacked images was processed 
using a deconvolution algorithm followed by 3-D reconstruction using the Huygens 
Essentials software. A region of interest (ROI) was drawn around a cell to obtain 
the isosurface volume and length of the mitochondrial network.  Sample size of 
each condition consist of n = 25 cells.  
Statistical Analysis  
All p values were generated between identified samples using unpaired two-tailed 
Student’s t-tests and represent analysis of ≥3 replicates per condition. Asterisks 
denote the following p values: *p<0.05, **p<0.001 and ***p<0.0001. 
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Chapter 5 
Perspective 
Overview 
ER and mitochondrial crosstalk: a regulator of inflammasome activation 
Inflammation is a double-edged sword, because it aids in resolution of 
infection but overexuberant inflammation can cause severe damage to the host.  
Individually, the ER and mitochondria have been shown to cooperate in triggering 
inflammation – the ER stress sensor IRE1 drives cytokine upregulation, while 
mitochondrial DAMPs activate the inflammasome. Although crosstalk frequently 
occurs between these two organelles, it was unclear whether ER-mitochondrial 
crosstalk was important for modulating an inflammatory response. Using the 
attenuated cattle vaccine strain of Brucella abortus RB51 as a model pathogen, I 
discovered that selective activation of host ER stress pathways can have different 
and profound effects on mitochondria leading to infection-associated 
proinflammatory signaling, inflammasome suppression, or cell death. Triggering 
the inflammasome by infection-induced ER stress required signaling through the 
IRE1-NLRP3-caspase-2-Bid axis upstream of the mitochondria. Suppression of 
the inflammasome could be mediated by PERK-induced mitophagy. If PERK was 
not activated then IRE1-mediated inflammation eventually resulted in a unique 
form of cell death with characteristics of both apoptosis (silent cell death) and 
pyroptosis (inflammatory cell death).  
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Novel roles for non-inflammatory proteins 
This thesis work has also uncovered surprising roles for proteins that did 
not have well-established functions in inflammation. Caspase-2 was classified as 
an apoptotic caspase with ties to metabolism, mitochondrial damage, and ER 
stress [1]. A previous study reported that caspase-2 could mediate caspase-1 
activation during a Salmonella macrophage infection [2]. No other study has been 
published to confirm this finding, and the mechanism by which caspase-2 
regulated caspase-1 was not identified. Here I show that caspase-2 does regulate 
caspase-1 activation by inducing mitochondrial damage, leading to inflammasome 
activation. Additionally, NLRP3 can regulate caspase-2 activation in response to 
ER stress. Classically, no other caspase besides caspase-1 is known to interact 
with NLRP3 – the interaction between NLRP3 and caspase-1 is mediated by ASC 
with contains both a CARD (caspase-1 interacting domain) and PYD domain 
(NLRP3 interacting domain). Although caspase-2 contains a CARD domain similar 
to caspase-1 [1], no reports have ever linked NLRP3 and caspase-2 together 
especially during inflammatory contexts, and it is intriguing to speculate that 
NLRP3 may interact with caspase-2 in a complex that is analogous to, but distinct 
from the canonical inflammasome.  
Similar to caspase-2, PERK had not previously been linked to control of 
inflammation. PERK is best known for its involvement in ER stress-induced cell 
death and upregulation of antioxidant capacity.  A previous study linked PERK to 
mitophagy, but in a non-infectious context. I discovered that specific microbial 
signals could activate PERK, which suppressed IL-1β production by triggering 
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removal of damaged mitochondria and mtDAMPs, ligands that stimulate 
inflammasome activation. My data are consistent with a suppressive role for PERK 
signaling during the inflammatory response to microbial infections both in vitro and 
in vivo. Since PERK suppresses inflammation, this UPR sensor may be useful as 
a therapeutic target for inflammatory diseases. By triggering PERK activation, one 
could reduce inflammation and pathology, thus increasing the health of patients 
who suffer from mitochondrial dysfunction-mediated diseases such as heart 
disease, Alzheimer’s, and diabetes.  My thesis research supports a role for ER as 
a critical hub for integrating cellular stress and innate immune signaling. 
Additionally, this work highlights the importance of maintaining the integrity of the 
mitochondrial network for minimizing inflammation. Even though we now have 
models that better define the regulatory role of ER-mitochondrial crosstalk in 
immune regulation, there are still questions that remain to be investigated. 
Broader impact of these pathways in infectious and non-infectious conditions 
 Although I used an attenuated vaccine strain to elucidate the regulatory 
mechanisms on inflammation licensed by the ER and mitochondria, I was able to 
demonstrate that these pathways occur during other infectious and non-infectious 
contexts. I found that in contexts where ER stress is triggered by chemical inducers 
(Chapter 3), IRE1 was essential for triggering inflammasome activation in a 
NLRP3/caspase-2/Bid dependent manner. Furthermore, Parkin-dependent 
mitophagy suppressed RSV- and HK RB51-induced IL-1β production (Chapter 4). 
The similarity of these pathways in different contexts aligns with previous work 
demonstrating that numerous stimuli (e.g. infection, irritants, injury, etc.) can elicit 
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cellular stress; therefore, it is not surprising that these pathways are crucial in 
different contexts. My thesis work highlights the potential role for ER-mitochondrial 
crosstalk in the broader context of clinically relevant infections and chronic 
inflammation. While some of the proteins described here were implicated in various 
inflammatory diseases, their connection to disease was previously unclear; my 
thesis research provides a framework and specific mechanisms by which cellular 
stress programs control inflammation. 
 Future Areas of Investigation 
What is the fate of the damaged mitochondria captured during mitophagy? 
 Captured cargo from autophagy and autophagy related processes are 
degraded and recycled for use by the cell [3]. In Chapter 3, I showed that damaged 
mitochondria fragment from the network and are captured in HK-infected BMDM. 
I have preliminary data that show these mitochondrial fragments are tagged by 
LC3 and released by the cell, suggesting that they are not autonomous but are 
surrounded by an autophagic membrane (Fig. A26). It is unclear if these fragments 
are intact mitochondria or mitochondrially derived vesicles (MDVs) [4]. Previous 
studies have illustrated that both mitochondria and MDVs can be released by cells. 
Released mitochondria are intact (lack signs of damage) and trigger inflammatory 
responses [5]. MDVs are cargo‐selective vesicles that bud off mitochondria in a 
Parkin-dependent manner [4, 6]. These MDVs are enriched for oxidized 
mitochondrial proteins and form in response to mitochondrial stress. The cargo 
(e.g. TOM20 positive or negative) and structure (single or double-membrane) of 
these MDVs can vary. I speculate that the observed extracellular mitochondrial 
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fragments are MDVs because these fragments are dependent upon Parkin and 
are associated with LC3. Intact mitochondria, when released, are not surrounded 
by a plasma membrane [5]. Although I have observed TOM20 positive fragments, 
it is unclear if other types of MDVs are being released by HK-infected BMDM. 
Immunostaining for mitochondrial proteins (PDH –matrix and Complex III – inner 
membrane) that have been identified in MDVs will further characterize the particles 
released by HK-infected BMDM. Additionally, I could probe for other proteins that 
I showed in Chapter 3 (e.g., caspase-2, NLRP3, Bid, etc.) to determine if they 
associate with these extracellular mitochondria. These vesicles/fragments may be 
carrying non-mitochondrial proteins that can trigger other cellular processes such 
as cell death or inflammation. Determining the molecular characteristics of MDVs 
will elucidate the as yet unknown function of extracellular mitochondrial fragments 
in the context of infection and inflammation. 
Currently, it remains unclear if these mitochondrial fragments would be 
perceived as pro-inflammatory or anti-inflammatory signals. It is known that 
apoptotic bodies when engulfed by a neighboring cell can be anti-inflammatory [7]. 
Since these mitochondrial fragments appear to be surrounded by an autophagic 
membrane, it is quite possible that, if sensed by recipient cells, they would not 
trigger the production of pro-inflammatory cytokines. Mitochondrial DAMPs can be 
detected in the bloodstream of patients suffering from systemic inflammatory 
response syndrome (SIRS), Acute Respiratory Distress Syndrome (ARDS), and 
acute lung injury (ALI) [8, 9]. These observations suggest that mitochondria 
contribute to immune responses and that these mtDAMPs are underappreciated 
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signaling molecules that may influence the course of disease. The genesis and 
regulation of mitochondrial vesicle formation has not been fully explored. 
Therefore, it is of interest to elucidate mechanisms of formation and extracellular 
release of these mitochondrial DAMPs/vesicles. Further investigation into the 
mechanisms and impact of these mitochondrial fragments may shed light on how 
cellular stress pathways exert long-range influence on other cells and organs 
during an inflammatory response. 
Why does mtROS increase when ROS-detoxifying mechanisms exist? 
 The mitochondrial network is the major production site of ROS, and 
excessive ROS production can be very toxic for the cell. Recent studies have 
illustrated that a NAD+ dependent deacetylase, Sirtuin-3 (Sirt3), can aid in 
detoxifying mtROS. Sirt3 localizes primarily in mitochondria and deacetylates 
several mitochondrial targets, including acetyl-CoA synthase 2, succinate 
dehydrogenase, manganese superoxide dismutase (MnSOD), and isocitrate 
dehydrogenase 2 [10]. Deacetylation of these targets allows Sirt3 to regulate 
oxidative phosphorylation and prevent oxidative damage. Recently, it was reported 
that DNA damage could trigger proteasomal degradation of Sirt3 leading to 
increased ROS production [11].  
In Chapter 3, the observation of a rapid and steady increase in ROS in Live-
infected BMDM suggested that there might be a deficiency in Sirt3. In Live-infected 
BMDM, I observed a significant decrease in Sirt3 activity and protein levels 
suggesting that Sirt3 was being inactivated or degraded (Fig. A27). There is little 
evidence to support Sirt3 degradation, especially during ER stress conditions. 
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These observations suggest that ER stress not only aids in the release of 
mitochondrial contents but can also regulate mitochondrial protein function. 
Degradation of Sirt3 could be viewed as a release on the inflammatory brake – by 
removing the brake, the cell can ramp up inflammation quickly and increase the 
chances of clearing the infection. My preliminary data show that Sirt3 degradation 
occurs during other types of microbial infections (Salmonella and MRSA, data not 
shown), suggesting that this degradation phenotype is not Brucella-specific but 
rather a broader phenomenon associated with infection. Degradation of Sirt3 could 
be mediated by (a) the mitochondrial localized proteasome, Lon [12, 13], or (b) 
exported from the mitochondria and degraded by the cytosolic ubiquitin-
proteasome system [14]. Sirt3 binds to heat shock protein 60 (HSP60), an 
interaction that may be critical for maintaining the presence of Sirt3 in the 
mitochondrial matrix [15]. During ER stress, there may be signals that destroy the 
Sirt3-HSP60 interaction thus leading to Sirt3 degradation. Currently, I am 
investigating whether Sirt3 degradation is mediated by the cytosolic ubiquitin-
proteasome system and what triggers Sirt3 degradation (e.g., TLR signaling, 
TXNIP translocation to mitochondria, calcium flux). Further investigation into what 
signals Sirt3 degradation is important because deficiency or mutations in SIRT3 
lead to increased inflammation in mice [16]. These data suggest that SIRT3 can 
regulate inflammatory outputs in response to infection and/or cellular stress. 
What role does calcium play in inflammation modulation? 
 Close interactions between the endoplasmic reticulum (ER) and 
mitochondria are essential for rapid and sustained Ca2+ uptake by mitochondria 
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[17]. VDAC, located in the outer mitochondrial membrane, is responsible for the 
rapid transfer of Ca2+ at mitochondrial-associated membranes (MAMs) or contact 
sites between ER and mitochondria. Increasing mitochondrial Ca2+ concentration 
activates dehydrogenases, thus increasing the electron flux and ATP production. 
Under homeostatic conditions, inositol 1,4,5 trisphosphate receptor (IP3R, located 
in the ER membrane) allows for regulated calcium transfer to the mitochondria. 
Interestingly, IP3R also inhibits autophagy by forming protein complexes with 
Beclin-1 and Bcl-2 [18]. If calcium transfer is inhibited, Ca2+-dependent stimulation 
of aerobic metabolism triggers autophagy due to the disruption of the Bcl-2/Beclin-
1/IP3R interaction. Preventing mitochondrial calcium uptake or massive calcium 
overload can trigger apoptosis. In healthy mitochondria, VDAC interacts with Bax 
and Bak to prevent the formation of Bak/Bax pores – pores that aid in the release 
of mitochondrial contents into the cytosol. Following an apoptotic stimulus, BID, a 
death agonist, is cleaved and binds to the outer mitochondrial membrane (OMM), 
where it activates Bax and Bak. Activated Bax and Bak promote OMM 
permeabilization and increase calcium leakage from the ER by interacting with 
IP3R [19]. This leads to the release of caspase cofactors into the cytosol thus 
triggering apoptosis. In addition to the release of proapoptotic factors, 
mitochondrial danger signals (mtDAMPs) are also released into the cytosol thus 
leading to inflammation, in particular inflammasome activation.  
 There are stark differences between the inflammatory response from Live 
RB51 and HK-infected BMDM. Live infection triggers excessive mitochondrial 
damage and pyroptosis (Chapters 2 and 3), whereas HK infection triggers 
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mitophagy (Chapter 4) and does not induce cell death [20]. Early in infection, both 
Live and HK-infected BMDM look similar; however, at 4h p.i. they begin to diverge. 
During the first two hours of infection by both Live and HK, there may be an influx 
of calcium from the ER into mitochondria, thus triggering a decrease in membrane 
potential and the stabilization of PINK1 on the outer membrane. Since at 4h p.i., 
Live-infected BMDM cleave Bid leading to outer mitochondrial membrane 
permeabilization, I hypothesize that mitochondrial damage possibly increases 
calcium efflux from the ER. This would increase mitochondrial calcium uptake and 
exacerbate mitochondrial damage. In HK-infected BMDM at 4h p.i., PERK is 
activated and induces Parkin upregulation. Parkin is recruited to the mitochondrial 
network and begins to ubiquitinate mitochondrial proteins, like VDAC, on the outer 
mitochondrial membrane, which would likely prevent further uptake of calcium into 
the mitochondria. To test this hypothesis, we can now take advantage of available 
mitochondria-specific calcium probes, including fusion proteins that carried 
calcium-sensitive photoproteins and GFP-based protein constructs engineered to 
change fluorescence properties following Ca2+ binding. With these tools, we will 
be able to measure changes in calcium concentration within the ER lumen and 
mitochondrial matrix, as well as more rigorously assess if differences in calcium 
flux are the key to modulating ER stress-induced inflammation.  
What feature of HK RB51 is essential for PERK activation? 
 Very little is known about the exact mechanism of ER stress activation by 
microbial ligands. Recent evidence has shown that activation sensitivity differs 
between UPR sensors [21]. In Chapter 3, I observed that HK, but not Live, 
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triggered PERK activation. HK bacteria could be viewed as a collection of microbial 
ligands. It is quite possible that our heat treatment changes protein structure, thus 
presenting ligands/epitopes that the cell would not normally see. To investigate 
whether microbial viability was the key to triggering PERK activation, I heat 
inactivated a variety of Gram-positive and -negative bacteria and measuring CHOP 
(a downstream target of PERK) induction. Only HK RB51 and the positive control 
tunicamycin (ER stress inducer) triggered CHOP induction – even at high MOI 
neither Salmonella (SL1344), Listeria (10403S) MRSA (USA300), nor E. coli 
(HB101) could trigger the PERK pathway (Fig. A28). Notably, all of the HK bacteria 
could trigger robust xbp1 splicing, indicating activation of the IRE1 ER stress 
sensor (data not shown). These data suggest that there is another factor 
responsible for triggering PERK activation. 
 Brucella abortus RB51 contains a Type 4 secretion system (T4SS) [22, 23], 
and heat killing RB51 would prevent the secretion of effector proteins into 
macrophages, because the bacteria are not metabolically active. If Live RB51 is 
actively suppressing PERK through an effector protein, then Live RB51 lacking a 
functional T4SS should trigger PERK activation. Infecting BMDM with Live 
RB51ΔvirB (T4SS) stimulated more PERK phosphorylation than wildtype Live 
RB51, but less than HK (Fig. A28). This is an interesting observation because 
virulent Brucella strains do induce PERK activation and contain a T4SS [24]. RB51 
is an attenuated laboratory strain derived from the virulent S2308 strain that was 
grown and passaged in media containing the antibiotic Rifampin [25]. Rifampin 
binds to the β subunit of the DNA-dependent RNA polymerase, and growth in 
421  
 
rifampin yields rough Brucella abortus colonies (deficient O antigen). Rifampin 
treatment also induced additional missense mutations (526 amino acids affected 
in total) in RB51 [25]. These observations suggest that an effector protein secreted 
through the T4SS is defective in PERK activation by Live RB51 due to mutations 
that alter expression or function of the effector protein. A recent study reported that 
four Brucella effector proteins (BspA, BspB, BspD, and BspK) localized to the ER 
[23]. With these newly identified ER-localized effector proteins, we can detect 
mutations in these proteins by comparing the sequence of RB51 to its parent 
strain, S2308.  If there are any differences in sequence, we can then investigate 
whether the mutated effector protein in RB51 is responsible for the lack of PERK 
activation during Live infection. Additionally, by infecting macrophages with WT 
RB51 and RB51+WTeffector we could do a co-immunoprecipitation assay to 
assess interaction between the effector and PERK. If there are differences that 
interrupt interaction, then we would demonstrate that bacterial effector proteins 
can modulate ER stress sensors.  
Conclusions and Significance of Thesis 
This thesis addresses an open question in the innate immunity field of how 
cellular stress can lead to control of inflammation, specifically the inflammasome. 
My data show that the partnership between the ER and mitochondria is essential 
for fine-tuning the immune response during infection. ER stress sensors can either 
induce mitochondrial damage to trigger an immune response or remove fragments 
of the mitochondrial network to dampen an immune response. Since ER 
components can trigger or suppress inflammation depending on the context, it 
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might be possible to customize immune responses – either increase inflammation 
to shorten time for microbial clearance (trigger IRE1) or dampen an immune 
response during disease to decrease tissue damage (trigger PERK). Researchers 
are now discovering that many pathogens can exploit these cellular stress 
programs to increase their survival and dampen the immune response – thus 
providing a strong rationale for a better mechanistic understanding of these stress 
pathways and their influence on immune responses.  Furthermore, these three ER 
stress sensors have been implicated in promoting insulin secretion, differentiation, 
lipid biosynthesis, and neurite outgrowth. By selectively activating or deactivating 
these stress programs using small molecule compounds, it may be possible to 
modulate cellular function and treat disease where these functions are altered. The 
results described in this thesis are relevant to understanding how ER stress might 
influence many diseases. Overall, the molecular context of cellular stress is critical 
in defining the pathways that govern cellular function, infection and inflammation.  
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Appendix 
 
Purpose 
The following section contains figures supplemental to the main chapter 
discussions. Figures A1-A3 were supplemental material published in the Frontiers 
of Cellular and Infection Microbiology and are referenced in Chapter 2. Figures A4-
A19 were included as supplemental material in the submitted IRE1 manuscript and 
are referenced in Chapter 3. Figures A20-A25 are supplemental data for the PERK 
data and are referenced in Chapter 4. Figures A26-A28 represent data that do not 
form a complete scientific story and are referenced in Chapter 5 as ideas that 
should be investigated further.  
Figure A1: Caspase-2 mediates RB51-induced macrophage cell death. (A)
Annexin V/propidium iodide (PI) staining of RB51-infected WT and casp2-/-
BMDMs at 100X magnification. Images are representatives of n≥3 independent
experiments. (B) LDH release in Live RB51-infected WT and casp2-/- BMDMs.
Cells were counted in randomly selected fields of 100 cells. (C) CFU analysis
of RB51 in WT and casp2-/- BMDMs, Error bars represent mean ± SD of n≥3
independent experiments. **p < 0.001 and ***p < 0.0001, Student’s t-test. n.s.
= not significant.
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Figure A2: Caspase-3 and -8 are involved in RB51-induced cell death. (A)
Caspase-2 cleavage (activation) in Live RB51-infected RAW264.7 macrophages
with or without Z-DEVD-FMK (20 µM, Caspase-3 inhibitor). (B) Caspase-2
cleavage (activation) in Live RB51-infected RAW264.7 macrophages with or
without Z-IETD-FMK (20 µM, Caspase-8 inhibitor). UNT and ET represent
untreated and etoposide (25 µM, 6hr treatment) respectively. Immunoblots are
representatives of n≥3 independent experiments.
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Figure A3: Caspase-1 aids in RB51-induced pore formation. RB51-infected
RAW264.7 macrophages treated with Z-YVAD-FMK (20 µM, caspase-1 inhibitor)
were stained with the membrane permeable dye Hoechst 33342 (blue) and the
membrane impermeant dyes (red), EtBr (MW 394) or EthD2 (MW 1293).
Adherent cells were visualized by fluorescence microscopy (100x). Images are
representatives of n≥3 independent experiments.
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Figure A4: RB51 infection does induce IL-1β production but no cell
death. (A) LDH release of RB51-infected (MOI 200) BMDMs. Lysed (Triton-
X100 treated) and untreated (UNT) cells served as positive and negative
controls respectively. (B) IL-1β levels in macrophages treated with LPS+ATP
(200 ng/mL and 1mM respectively) or infected with RB51-infected at MOI
200 or 20. Error bars represent mean ± SD of n≥3 independent experiments.
*** represent p-value <0.0001 respectively. n.s. = not significant.
150
Figure A5: Chemical inhibitors do not affect bacterial uptake. BMDMs
were pretreated with TUDCA (chemical chaperone, 300 µM) or 4µ8c (IRE1
inhibitor, 50 µM) for one (1) hour prior to infection. These pretreated
BMDMs were then infected with RB51 (MOI 200). One (1) h.p.i BMDMs
were lysed to enumerate intracellular CFU. Error bars represent mean ±
SD of n≥3 independent experiments. n.s. = not significant. The inset
demonstrates the efficacy of 4µ8c inhibiting IRE1-induced xbp1 splicing in
TM (tunicamycin, 10 µg/mL) treated and RB51-infected BMDM.
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Figure A6: IRE1 is required for RB51-induced inflammasome activation.
(A) IL-1β levels and (B) caspase-1 cleavage in RB51-infected non-target (NT)
and IRE1KD RAW264.7 macrophages. UNT, L+A, and ET represent
untreated, LPS+ATP (positive control for IL-1β 200 ng/mL and 1 mM), and
etoposide (positive control for caspase-2 activation and Bid truncation, 25 µM)
respectively. Error bars represent mean ± SD of n≥3 independent experiments.
*** represent p-value <0.0001, n.s. = not significant. Immunoblots in (B) are
representative of n≥3 independent experiments that were performed and
imaged in parallel with identical parameters using a LiCor Odyssey imaging
system. Full length caspase-1serve as loading controls.
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Figure A7: IRE1 inhibition decreases bacterial killing in vivo. Mice were
intraperitoneally (i.p.) injected with Brucella abortus RB51 (CFU 1 x 108). Mice
were treated with 5% DMSO (n = 10) or 4µ8c (n = 10) on day 0 – 3 post
infection. The spleens were collected 3 days post infection and bacterial
numbers (CFU/mL) were measured. The data were pooled from 2 separate
experiments. *** represent p-value <0.0001.
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Fig. A8: IRE1 inhibition does not affect priming. qPCR analysis of 
NLRP3 transcript levels RB51-infected BMDMs in absence or 
presence of 4µ8c. 
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Figure A9: IRE1 is required for RB51-induced cytochrome c release.
Immunoblot analysis of cytochrome c (cyto c) in cytosolic extracts from RB51-
infected BMDMs in (A) non-target or IRE1 KD RAW264.7 macrophages or in
(B) the absence or presence of 4µ8c (IRE1 inhibitor, 50 µM) – TMǂ denotes
the same control TM-treated sample. The blots were probed with anti-actin
antibody as a loading control. Immunoblots are representative of n≥3
independent experiments that were performed and imaged in parallel with
identical parameters using a LiCor Odyssey imaging system. UNT and TM
represent untreated and tunicamycin (10 µg/mL, positive control for ER stress
activation respectively.
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Figure A10: Cyclosporin A treatment has no effect on bacterial uptake.
BMDMs were pretreated with cyclosporin A (CsA, inhibitor of MPTP
opening 10 μM) for one (1) hour prior to infection. These pretreated BMDMs
were then infected with RB51 (MOI 200). One (1) h.p.i BMDMs were lysed
to enumerate intracellular CFU. Error bars represent mean ± SD of n≥3
independent experiments. n.s. = not significant
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Figure A11: AIM2 is not required for ER stress-induced IL-1β
production. ELISA analysis of IL-1β levels in the supernatant of WT and
aim2-/- RB51-infected BMDMs. Error bars represent mean ± SD of n≥3
independent experiments. n.s. = not significant. UNT (untreated) and
LPS+ATP (trigger of IL-1β production, 200ng/mL and 1mM) respectively.
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Figure A12: NLRP3, not ASC or caspase-1, is essential for RB51-induced
mitochondrial dysfunction. (A) Immunoblot analysis of cytochrome c (cyto c)
in cytosolic extracts from RB51-infected WT and nlrp3-/- BMDMs – TMǂ
indicates duplicate lanes of the same sample. (B) Immunoblot analysis of
caspase-1 in RB51-infected WT and nlrp3-/- BMDMs – L+Aǂ indicates
duplicate lanes of the same sample. (C) Immunoblot of cytochrome c in WT,
asc-/-, and Y-VAD-CHO (caspase-1 inhibitor, 2 µM) treated BMDMs. Actin and
full length (FL) caspase-1 serve as a loading control. The cleaved active form
(Cl) was detected on the same blot as FL.
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Figure A13: Inhibition of caspase-1 has no effect on bacterial
uptake. BMDMs were pretreated with Z-YVAD-CHO (caspase-1
inhibitor, 2 µM) for one (1) hour prior to infection. These pretreated
BMDMs were then infected with RB51 (MOI 200). One (1) h.p.i BMDMs
were lysed to enumerate intracellular CFU. Error bars represent mean ±
SD of n≥3 independent experiments. n.s. = not significant
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Figure A14: Caspase-2 triggers mitochondrial damage via IRE1 and
NLRP3. Caspase-2 activation in (A) non-target (NT) and IRE1 KD or (B) WT,
asc-/-, and Y-VAD-CHO (caspase-1 inhibitor, 2 µM) treated BMDMs. (C)
cytochrome c release in WT and casp2-/- BMDMs infected with RB51. (D)
Bacterial uptake in WT and casp2-/- BMDMs 1 hour post infection. (E)
Immunoblot of caspase-1 cleavage (activation) in WT and casp2-/- BMDMs
infected RB51. UNT, ET, and L+A represent untreated, etoposide (inducer of
caspase-2 activation, 25 µM), and LPS+ATP (trigger of IL-1β production,
200ng/mL and 1mM) respectively. (F) qPCR analysis of NLRP3 transcript
levels RB51-infected WT and casp2-/- BMDMs. Immunoblots are
representative of n≥3 independent experiments that were performed and
imaged in parallel with identical parameters using a LiCor Odyssey imaging
system. Actin and full length (FL) caspase-2 serve as loading controls.
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Figure A15: ER stress-induced caspase-2 mediates Bid truncation.
Immunoblot analysis of Bid truncation in (A) non-target and IRE1KD
RAW264.7 macrophages or (B) WT and casp2-/- BMDMs infected with RB51
– ETǂ identifies duplicate lanes of the same sample. UNT and ET represent
untreated and etoposide (inducer of caspase-2 activation, 25 µM)
respectively. (C) Bacterial uptake in WT and bid-/- BMDMs 1 hour post
infection. Immunoblots are representative of n≥3 independent experiments
that were performed and imaged in parallel with identical parameters using a
LiCor Odyssey imaging system. Full length (FL) Bid serves as loading
controls.
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Figure A16: Bid is required for bacterial killing in vivo. WT (n=29)
and bid-/- (n = 30) mice were intraperitoneally (i.p.) injected with Brucella
abortus RB51 (CFU 1 x 108). The spleens were collected 3 days post
infection and bacterial numbers (CFU/mL) were measured. The data was
pooled from 2 separate experiments. *** represent p-value <0.0001.
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Figure A17: ER stress triggers weak priming of proIL-1β. (A) ProIL-1β
and (B) xbp1 splicing in BMDMs after 4 hour treatment with LPS, as well as
ER stress inducers thapsigargin (TG, 10 µM), tunicamycin (10 µg/mL), and
brefeldin A (BFA, 20 µM). CHOP serves as a marker of ER stress and actin
serves as a loading control. Immunoblots in (A) are representative of n≥3
independent experiments that were performed and imaged in parallel with
identical parameters using a LiCor Odyssey imaging system.
163
Figure A18: Amount of stress determines route of inflammasome
activation. (A) Amount of mtDNA released into the cytosol when treated
with two different L+A treatment protocols. (B) Immunoblot of proIL-1β
protein levels in cell treated with LPS (200 ng/ml) overnight (o/n) or for 4 hrs
prior to ATP treatment.
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Figure A19: Purity of mitochondrial fraction. Whole Cell lysate (WCL),
cytosolic fraction (CF), and mitochondrial fraction (mtF) are assessed for the
presence of different cellular markers: Calreticulin (ER marker), TOM20
(mitochondrial marker), Lamin B1 (nuclear marker), and Actin (cytosolic
marker).
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Figure A20: Both Live and HK RB51 induce IRE1 and ATF6 activation.
(A) xbp1 splicing, in Live and HK RB51-infected (MOI 20) BMDM. qRT-PCR
samples were treated with PstI to distinguish between spliced (184 bp) and
unspliced variants (119 bp following PstI digestion). (B) Immunoblot of ATF6
cleavage in Live and HK RB51-infected BMDM. UNT and TM represent
untreated and tunicamycin (10 µg/mL, positive control for ER stress
activation).
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Figure A21: Deficiency in ATF4 leads to increased mitochondrial damage.
(A) Amount of mtDNA released into the cytosol by Live and HK-infected BMDM
in the presence of non-target or ATF4 specific siRNA. (B) CM-H2DCFDA was
used to measure ROS levels in non-target or ATF4 siRNA treated BMDM
infected with Live and HK-RB51. (C) Immunoblot of mitophagy markers PINK1,
LC3-II, and Parkin in the mitochondrial fraction of CCCP and Live/HK-infected
BMDM in the presence of non-target or ATF4 siRNA. (D) 3-D reconstruction and
quantification of the mitochondrial network labeled with TOM20 (mitochondrial
marker, outer membrane protein) with or without ATF4 siRNA in CCCP and
Live/HK-infected BMDM. Colors represent the size of the fragments within the
network. Error bars in (A, B, and D) represent mean ±SD of n≥3 independent
experiments. ** and *** represent p-values <0.001 and <0.0001 respectively.
n.s. = not significant. UNT, CCCP, and TM represent untreated and Carbonyl
cyanide m-chlorophenyl hydrazine (20 µM, positive control for mitophagy
induction), and tunicamycin (10 µg/mL, positive control for ER stress-induced
mitochondrial damage).
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Figure A22: LC3b deficiency does not prevent mitochondrial fragmentation.
3-D reconstruction and quantification of the mitochondrial network labeled with
TOM20 (mitochondrial marker, outer membrane protein) in CCCP and Live/HK-
infected WT or lc3b-/- BMDM. Colors represent the size of the fragments within
the network. Error bars in represent mean ±SD of n≥3 independent experiments
where n.s. = not significant. UNT and CCCP, represent untreated and Carbonyl
cyanide m-chlorophenyl hydrazine (20 µM, positive control for mitophagy
induction).
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Figure A23: PERK inhibition decreases Parkin transcription in
RSV-infected BMDM. qPCR analysis of Parkin transcription during
RSV BMDM infection (MOI 1) in the absence or presence of GSK-
PERK (GSK2606414, 5 μM). Tunicamycin (TM) serves as a positive
control for PARKIN induction. Error bars represent mean ± SD of n≥3
independent experiments. ** represents p-values of <0.001, n.s. = not
significant.
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Figure A24: PERK and Parkin suppress RSV-induced caspase-1
activation. Caspase-1 cleavage during RSV (MOI 1) infection (A) in absence
or presence of GSK-PERK (5 μM) or (B) WT and parkin-/- BMDM.
Immunoblots in (A) and (B) are representative of n≥3 independent
experiments performed and imaged using a LiCor Odyssey imaging system.
UNT and L+A represent untreated and LPS+ATP (200 ng/mL and 1mM
respectively; positive control for inflammasome activation).
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Figure A25: ATF4 knockdown efficiency in BMDM. Non-target and ATF4
siRNA BMDM were treated with TM to induce ATF4. Knockdown of ATF4 was
assessed during each experiment and percent of knockdown efficiency was
normalized to Actin. Immunoblot is representative of n≥3 independent
experiments performed and imaged using a LiCor Odyssey imaging system.
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Figure A26: HK-infected BMDM release mitochondria into media.
(A) BMDM were immunostained with TOM20 (mitochondrial marker)
and DAPI (nuclear marker). Cells were counterstained with Phallodin to
determine the outline of the cell (denoted by white dashed line). (B)
Extracellular mitochondrial fragments from CCCP treated and HK-
infected (MOI 20) BMDM were stained with TOM20 and LC3 (autophagy
marker). (All images in A-C are representative of n≥3 independent
experiments.
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Figure A27: Live RB51 induces Sirt3 degradation. (A) Lysates of Live-
infected BMDM were used to measure Sirt3 activity via fluorescence.
Percent activity was determined by comparing infection fluorescence values
to untreated fluorescence values. (B) Immunoblot of Sirt3 in L+A treated or
Live infected BMDM in the presence or absence of Epoximicin (proteasome
inhibitor, 5 µM) or 4u8c (IRE1 specific inhibitor, 50 µM. Immunoblots are
representative of n≥2 independent experiments performed and imaged in
parallel with identical parameters using a LiCor Odyssey imaging system.
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Figure A28: Secretion system not viability mediates PERK
activation. (A) Immunoblot of CHOP in the presence of Brucella (RB51),
E. coli (HB101), Listeria(10403S), Salmonella (SL1344), and MRSA
(US300). Tunicamycin (TM) serves as a positive control for CHOP
induction. (B) PERK phosphorylation in RB51ΔvirB-infected (Type 4
secretion system mutant, MOI 20) BMDM. PERK and TM served as the
loading and positive controls respectively. Immunoblots are
representative of n≥3 independent experiments performed and imaged in
parallel with identical parameters using a LiCor Odyssey imaging system.
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